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Summary 
Natural Killer (NK) cells are innate immune cells that can eliminate malignant and 
foreign cells and that play an important role for the early control of viral and fungal 
infections. Further, they are important regulators of the adaptive and innate immune 
responses. During their development in the bone marrow (BM) NK cells undergo 
several maturation steps that directly establish an effector program. The 
transcriptional network that controls NK cell development and maturation is still 
incompletely understood. Based on earlier findings that NK cell numbers are reduced 
in the absence of the transcription factor T cell factor-1 (Tcf-1), my thesis has 
addressed the precise role of this transcription factor for NK cell development, 
maturation and function and whether Tcf-1 acts as a nuclear effector of the canonical 
Wnt signaling pathway to mediate its effects. It is shown that Tcf-1 is selectively 
required for the emergence of mature BM NK cells. Surprisingly, the emergence of 
BM NK cells depends on the repressor function of Tcf-1 and is independent of the 
Wnt pathway. In BM and peripheral NK cells Tcf-1 is found to suppress Granzyme B 
(GzmB) expression, a key cytotoxic effector molecule required to kill target cells. We 
provide evidence that GzmB over-expression in the absence of Tcf-1 results in 
accelerated spontaneous death of bone marrow NK cells and of cytokine stimulated 
peripheral NK cells. Moreover, Tcf-1 deficient NK cells show reduced target cell 
killing, which is due to enhanced GzmB-dependent NK cell death induced by the 
recognition of tumour target cells. Collectively, these data provide significant new 
insights into the transcriptional regulation of NK cell development and function and 
suggest a novel mechanism that protects NK cells from the deleterious effects of 
highly cytotoxic effector molecules.  

Résumée 
	   iii	  
Resumé 
Les cellules NK (de l’anglais Natural Killer) font partie du système immunitaire inné et 
sont capables d’éliminer à elles seules les cellules cancéreuses ou infectées. Ces 
cellules participent dans la régulation et la coordination des réponses innée et 
adaptative. Lors de leur développement dans la moelle osseuse, les cellules NK vont 
acquérir leurs fonctions effectrices, un processus contrôlé par des facteurs de 
transcription mais encore peu connu. Des précédentes travaux ont montré qu’une 
diminution du nombre de cellules NK corrélait avec l’absence du facteur de 
transcription Tcf-1 (T cell factor-1), suggérant un rôle important de Tcf-1 dans le 
développement de cellules NK. Cette thèse a pour but de mieux comprendre le rôle 
du facteur de transcription Tcf-1 lors du développement et la maturation des cellules 
NK, ainsi que son interaction avec la voie de signalisation Wnt. Nous avons montré 
que Tcf-1 est essentiel pour la transition des cellules immatures NK (iNK) à des 
cellules matures NK (mNK) dans la moelle osseuse, et cela de manière 
indépendamment de la voie de signalisation Wnt. De manière intéressante, nous 
avons observé qu’en absence du facteur de transcription Tcf-1, les cellules NK 
augmentaient l’expression de la protéine Granzyme B (GzmB), une protéine  
essentielle pour l’élimination des cellules cancéreuses ou infectées. Ceci a pour 
conséquence, une augmentation de la mort des cellules mNK dans la moelle 
osseuse ainsi qu’une diminution de leur fonction «tueuses». Ces résultats montrent 
pour la première fois, le rôle répresseur du facteur de transcription Tcf-1 dans 
l’expression de la protéine GzmB. L’ensemble de ces résultats apporte de nouveaux 
éléments concernant le rôle de Tcf-1 dans la régulation du développement et de la 
fonction des cellules NK et suggèrent un nouveau mécanisme cellulaire de protection 
contre les effets délétères d’une dérégulation de l’expression des molécules 
cytotoxique.
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1 Introduction 
1.1 Cells and organs of the immune system 
The lymphoid organs such as the thymus, spleen and lymph nodes are central 
components of the mammalian immune system. The thymus and the bone marrow 
(BM) are the primary (or central) lymphoid organs. They provide an appropriate 
microenvironment for the development and maturation of lymphocytes. All blood cells 
including all immune cells arise from haematopoietic stem cells (HSC). This process, 
called haematopoiesis, takes place within the bone marrow throughout adult life. 
HCS have the capacity for self-renewal and are maintained at a stable level. Early in 
haematopoiesis, pluripotent stem cells can differentiate either into common lymphoid 
progenitor (CLP) cells or common myeloid progenitor (CMP) cells. These cells have 
lost the capacity of self-renewal and are committed to a particular cell lineage. CLP 
cells give rise to B, and natural killer (NK) cells. CMP cells generate progenitors of 
red blood cells (erythrocytes), many of the various white blood cells (neutrophils, 
eosinophils, basophils, monocytes, mast cells), and platelet-generating cells called 
megakaryocytes. 
The cells of the adaptive immune system (B and T lymphocytes) undergo further 
differentiation steps within primary lymphoid organs (T cells in the thymus and B cells 
in the bone marrow) to acquire their specificity and to generate antigen (Ag)-receptor 
diversity. This is achieved through the clonal expression of B cell receptors (BCRs) 
and T cell receptors (TCRs) with distinct antigen specificities, the diversity of which 
results from random somatic DNA rearrangements. The recombination events yield a 
high number of antigen receptors, some of which are potentially self-reactive. A 
central selection process eliminates potentially harmful T and B cells that possess 
self-reactive receptors.  
The secondary lymphoid tissues (SLT) including lymph nodes (LNs), the spleen, 
Peyer`s patches and the gut- and bronchus-associated lymphoid tissues play an 
important role during the development of an adaptive immune response. They are 
highly organized structures, which trap and concentrate the Ag and allow the 
interaction of Ag-bearing antigen-presenting cells (APCs) with the rare Ag specific T 
and B cells. 
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1.2 Innate and adaptive immunity 
The mammalian immune system consists of the Ag-non-specific innate immunity and 
the Ag-specific adaptive immunity. These two arms interact with each other. In 
contrast to innate immunity, which develops within hours after encountering a 
pathogen, the adaptive immunity develops over the course of days. Additionally, the 
adaptive immunity exhibits memory that allows a faster and stronger response upon 
re-exposure to the Ag. 
The first defense against pathogens is our body surface, the skin and the epithelial 
barriers of gastrointestinal, respiratory and urogenital tracts. These barriers are 
populated by sensors of the innate immune system, such as dendritic cells (DCs) and 
macrophages. As a component of the innate immune system, they screen their 
environment for pathogens using germ line encoded receptors called pattern-
recognition receptors (PRRs). PRR recognize a limited but highly conserved set of 
molecular structures, the pathogen-associated molecular patterns (PAMPs), which 
are absent in the host (Imler and Hoffmann, 2001). If a pathogen is recognized by 
components of the innate immune system, a cascade of events takes place within a 
few hours and this results in an inflammatory response. This leads to the recruitment 
of more cells of the innate immune system to this site of infection to eliminate the 
pathogens. 
The most prominent PRRs expressed by macrophages and DCs, are the scavenger 
receptors and the Toll-like receptors (TLRs). The TLRs are capable of recognizing 
organisms ranging from bacteria to fungi, protozoa and viruses, and they play a 
major role in innate immunity (Uematsu and Akira, 2008). To date, 12 TLRs are 
known in mice and 11 in humans. Stimulation of TLRs results in an increased 
phagocytic activity, a release of inflammatory mediators and the secretion of 
cytokines. The increased phagocytic activity of the APCs leads to a higher chance of 
capturing Ags for presentation by major histocompatibility complex (MHC) molecules 
(Reis e Sousa, 2006). The Ags taken up are cleaved into peptides in the endocytic 
compartments and loaded onto MHC-II molecules (MHC-II) , which present the Ag on 
the cell surface to CD4 T cells. In contrast MHC class I (MHC-I) presents antigens 
derived from cytosolic or nuclear proteins. Exogenous antigenic peptides can also be 
presented by MHC-I molecule using a process called cross-presentation. Cross-
presentation is essential for inducing cytotoxic T-lymphocyte (CTL) responses 
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against most tumors and against viruses that do not readily infect antigen-presenting 
cells and it is important for induction and maintenance of tolerance directed to self 
antigens (Banchereau and Steinman, 1998; Bevan, 2006; Neefjes and Sadaka, 
2012). DCs are the only APCs able to activate naïve T lymphocytes and are the most 
powerful APCs in higher vertebrates. Following maturation induced by inflammatory 
mediators and microbial products and the uptake of Ags, DCs migrate to the T-cell 
area of the draining lymph nodes. During their journey they down-regulate their 
capacity to take up Ags and up-regulate Ag-MHC-II complexes, co-stimulatory 
molecules (e.g. cluster of differentiation (CD)40, CD80 and CD86) and the 
chemokine receptor CCR7. The CCR7 is the main lymph-node homing receptor and 
enables the DCs to migrate to lymph nodes through peripheral lymphatic vessels 
(Forster et al., 1999). There they initiate the activation and expansion of T cells 
recognizing their cognate Ag. 
The central event in the generation of both humoral and cell-mediated immune 
responses is the activation and clonal expansion of rare antigen-specific T and B 
cells. Mature T cells are constantly circulating through the blood, lymph and SLTs 
such as LNs and the spleen. SLs have evolved in order to trap and concentrate Ag 
and to allow the interaction of Ag-laden APCs with rare Ag-specific T and B cells. The 
highly organized SLTs contain defined compartments consisting of T cell areas and B 
cell areas. 
Circulating T lymphocytes enter the LN via the T cell area where they interact with 
Ag-laden DCs. T lymphocytes specific for the foreign Ag are thus activated and 
expand clonally. Upon differentiation, they either leave the LNs in order to migrate 
through the body in search of their cognate Ag displayed by resident APCs, infected 
or malignant cells. Alternatively they home to the B cell areas to assist in Ag-specific 
antibody production. T lymphocytes only recognize processed peptide antigens 
presented on MHC molecules. The cytotoxic CD8+ T cells react to peptides bound on 
MHC-I that are expressed by virtually all cells of the body. The CD4+T cells recognize 
MHC-II bound peptides. MHC-II molecules are only expressed by professional APCs. 
A contact between an APC providing a suitable MHC/peptide complex and an 
additional co-stimulatory signal is required for the activation of a CD4+ T cell, a 
process called priming. The CD4+ T cells provide help during the process of CD8+ T 
cell and B cell priming. Dependent on the cytokine environment the CD4+ T cells can 
differentiate into various subset types with functions that depend on the array of 
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cytokines they produce. For example, regulatory T cells that maintain peripheral 
tolerance or Th17 cells that promote inflammation (Welsh and Selin, 2002).  
Activated CD8+ T cells are able to directly destroy target cells that present their 
cognate Ag on MHC-I molecules. They induce apoptosis of the target cell either via 
the release of the cytotoxic molecules Perforin (Prf1) and Granzymes (Gzm) or 
trough Fas-Fas-ligand interactions. Most of the clonally expanded CD8+ T cells die 
once the pathogen is cleared, leaving behind a population of long-lived memory 
CD8+ T cells. 
 
1.3 NK cells in health and disease 
The NK cells belong to the innate branch of the immune system. They were named 
based on their ability to eliminate tumor cells, without the need for prior sensitization. 
NK cells circulate in the blood and they can be found in the bone marrow, spleen, 
liver, lung and lymph nodes. They are rapidly attracted to the sites of inflammation. 
NK cells are able to directly kill infected or aberrant cells and to provide activating 
signals to DCs and macrophages. Therefore they are important to maintain a first line 
of defense while the adaptive immune response is building up (Hepworth and 
Sonnenberg, 2014; Moretta et al., 2005; Vivier et al., 2011) (Fig. 1). They play a role 
in the early control of viral infections in humans and mice. The control of several virus 
infections in mice including influenza virus, murine hepatitis virus (MHV), ectromelia 
poxvirus and murine cytomegalovirus (MCMV), depends on NK cells. Mice show 
increased susceptibility or resistance to MCMV after NK cell depletion or NK cell and 
adoptive transfer, respectively (Bukowski et al., 1983; Lee et al., 2007). In line with 
those findings human patients lacking NK cells are susceptible to herpesvirus 
infections that are otherwise harmless (Biron et al., 1989; Orange, 2006).  
 Recently, a critical role for NK immunity to systemic fungal infections has been 
reported. NK cell deficiency causes high susceptibility to C. albicans infections, and 
adoptive transfer of NK cells restores the ability of mice to control the infection (Bar et 
al., 2014). The role of NK cells in the control of bacterial infections is less well defined 
yet.  
NK cells can also play a role in tumor control. Mouse NK cells are involved in the in 
vivo rejection of transplanted tumors, in a manner dependent upon the presence or 
absence of NK cell receptor ligands expressed by the tumor (Diefenbach et al., 2001; 
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Marcus et al., 2014). Furthermore it has been shown that NK cells are able to 
eliminate methylcholanthrene (MCA)-induced sarcomas (Smyth et al., 2001; 
Yokoyama, 2005). NK cell infiltrates in human tumor biopsies, such as in colorectal 
carcinoma and gastric carcinoma, are associated with favorable prognoses (Coca et 
al., 1997; Ishigami et al., 2000). As a consequence, several recent therapeutic 
approaches aim at boosting the tumoricidal activity of NK cells (Ames and Murphy, 
2014).  
NK cells also have the ability to reject bone marrow allografts in lethally irradiated 
mice. Hematopoietic stem cell transplants (HSCT) using a MHC-I mismatch between 
recipient and donor can be rejected by NK cells. Conversely, in the context of 
hematological malignancies NK cells can improve the therapeutic success of partial 
human leucocyte antigen (HLA) mismatched hematopoietic stem cell transplantation 
by mediating a graft versus tumor (GvT) effect. A GvT occurs when cytotoxic immune 
cells like NK cells or T cells of the graft recognize malignant cells of the host as 
“foreign” and mount an immune response against them (Ruggeri et al., 2002). While 
NK cells can mediate GvT, they do not mediate graft versus host disease (GVHD), 
which is in contrast to T cells. GVHD occurs when grafted immune cells attack 
normal host tissues such as the skin, liver, and lungs.  
Activated NK cells are an early source of interferon-γ (INFγ), which can directly affect 
the survival of pathogens. Furthermore they can secrete the tumor-necrosis factor 
(TNF) that together with INFγ can prevent the growth and spread of tumors. 
NK cells also play an important role as regulators of adaptive immune responses. 
They can kill activated T cells, APC and endothelial cells and thereby dampen 
potentially harmful immune responses. Conversely NK cells can enhance adaptive 
immune responses by mediating DC maturation and by promoting T helper 1 (Th1) 
cell priming in lymph nodes via the secretion of INFγ (Laouar et al., 2005; Martin-
Fontecha et al., 2004) (Fig.1).  
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Figure 1. NK cells play an important role in innate and adaptive immunity 
The table shows the most important functions of activated NK cells in innate and 
adaptive immunity. 
Picture was taken by confocal microscopy and shows an activated NK cell at day 5 
of IL-2 stimulation. The green granules within the cytoplasm depict Granzyme B 
(GzmB). The nucleus was stained with DAPI and is shown in blue. The white 
reflections depict parts of the the cytoplasm.  
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Regulatory T cells are important for the maintenance of peripheral tolerance. Their 
presence and/or activity is reduced in autoimmune conditions and increased in 
tumors. Regulatory T cells can inhibit NK cell activity by restricting the availability of 
IL-2, which is released by activated CD4+ T cells. Conversely, NK cells can eliminate 
regulatory T cells. It has been shown in several autoimmune diseases, like multiple 
sclerosis, that NK cells can attack host tissues (Kaur et al., 2013). In contrast, certain 
NK cell subsets may prevent autoimmunity, as they can secrete the regulatory 
cytokines TGFβ and IL10 (Fig. 1) (Kerdiles et al., 2013; Poggi and Zocchi, 2014).  
Alltogether, besides direct protective effects against infection, NK cells are 
modulating many aspects of adaptive immunity (Fig. 1). 
1.4 NK cell development 
During embryogenesis NK cells develop mainly in the fetal liver, whereas in adult 
mice the primary site for NK cell development is the BM. Nevertheless, a small 
number of NK cells continue to develop in the liver and the thymus (Constantinides et 
al., 2014; Daussy et al., 2014). NK cells develop from the common lymphoid 
progenitor (CLP) that can be characterized as lineage-negative (Lin-) (negative for 
mature cell lineage markers) and by the expression of the interleukin (IL)-
7Rα (CD127) and the growth factor receptor c-Kit (lineage- IL-7Rα+ c-Kit+). CLPs are 
oligopotent and can also give rise to B cells and to a small extend to T cells, but they 
have lost the myeloid lineage potential. Carotta et al. recently identified the earliest 
committed NK cell progenitor with the help of an inhibitor of DNA binding-2 (Id2)-GFP 
reporter mouse. They found a small population of GFP+ cells in the Fms-related 
tyrosine kinase 3 ligand (Flt-3L)+ CLP fraction (Lin- Id2+ stem cell antigen-1 (Sca1)+ 
CD127+ c-Kitlow Flt-3L+ CD122-). These GFP+ cells efficiently differentiated into NK  
cells in vitro while having lost T and B cell potential (Carotta et al., 2011). At the 
same time Fathman et al. identified an NK cell progenitor within the CLP population 
using the surface markers CD244 (2B4) and CD27 (Lin-CD27+CD244+CD127+). In 
vivo and in vitro assays revealed that those cells were committed to the NK cell 
lineage (Fathman et al., 2011).  
Subsequently, NK cell committed progenitors up-regulate the IL-15 receptor complex, 
composed of IL-15 receptor α (IL-15Rα), IL-2Rβ (CD122), and IL-2 receptor common 
γ (IL-2Rγc) chains. At this stage they are named natural killer progenitor (NKP) and 
they have lost the ability to differentiate into a B or T cell (FIg. 2). The NKP cells 
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subsequently progress to an immature NK cell (iNK) stage defined by the acquisition 
of NK1.1 as well as NKG2D receptors (Rosmaraki et al., 2001). The iNK cell stage 
correlates with the expression of receptors for MHC class I-molecules including 
CD94 in combination with NKG2A/C/E, and Ly49 receptors, a family of c-type lectin-
like receptors.  
 
 
Figure 2. NK cell development in the bone marrow. 
NK cells arise from a common lymphoid progenitor (CLP). The first progenitors that are exclusively 
committed to the NK cell lineage are called NK cell precursors (NKP) and they can be identified by 
the expression of the IL-2/15Rβ receptor. Immature NK cells (iNK) cells can be characterized by the 
expression of NK1.1 and the lack of DX5. The later marks the mature (mNK) stage. During the iNK to 
mNK transition NK cell sequentially up-regulate the expression of activating and inhibitory receptors 
including the Ly49 family of receptors. The mNK stage correlates with extensive expansion and the 
up-regulation of maturation markers like CD11b, CD43 and KLRG1. During their maturation process 
NK cells are programmed for their effector potential. At the iNK stage they start to accumulate an 
mRNA pool for GzmB, Perforin and INFγ but the expression of these effector molecules is prevented 
until priming. The model shows the essential markers that we use in the result section to analyze BM 
development. 
 
In the next developmental step, BM NK cells up-regulate the integrin DX5/CD49b and 
are considered mature (mNK) cells. The hallmark of this phase is the extensive 
expansion and the acquisition of effector functions such as cytotoxic activity and INFγ 
production. NK cells then sequentially up-regulate the maturation markers CD11b 
followed by CD43 and S1PR5, a receptor for sphingosine-1 phosphate that induces 
their exit from the BM to the periphery (Jenne et al., 2009). During this process CD27, 
a marker for immature NK cells, is down regulated. Few mNKs in the BM express 
KLRG1, which correlates with end stage maturation. KLRG1 and CD27 are 
expressed in a mutually exclusive fashion on NK cells (Huntington et al., 2007). In 
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the periphery KLRG1 is up-regulated upon homeostatic proliferation or infection and 
marks cellular senescence (Fig. 2) (Huntington et al., 2007; Robbins et al., 2004).  
1.5 NK cell function 
NK cells use germline-encoded receptors to distinguish altered or non-self cells from 
normal host cells. NK cells employ two different categories of receptors: one that 
delivers inhibitory signals and another that delivers activation signals. NK cells 
constantly scan the cells of the body and integrate the activating and inhibitory 
signals that they receive (Barton et al., 1998). Healthy cells express MHC-I 
molecules that are recognized by specific inhibitory Ly49 (mouse), CD94/NKG2A 
(mouse or human) or KIR family receptors (human). Moreover, they constitutively 
express low amounts of self-ligands that are recognized by activating receptors on 
NK cells. Contact with a healthy cell that expresses MHC class I molecules signals 
balance and results in self-tolerant NK cells.  
 
 
 
Figure 3. The regulation of NK cell function (adapted from (Vivier et al., 2011)). 
NK cells employ two different categories of receptors: one that delivers inhibitory signals and another 
that delivers activation signals. NK cells constantly scan the cells of the body and integrate the 
activation and inhibitory signals that they receive. (A) The contact with a healthy cell that expresses 
self-MHC-I molecules and low amounts of activating ligands leads to an excess of inhibitory signals 
(bold red arrow) and a self-tolerant NK cell. A cell that is perturbed by viral infection or cellular 
transformation can either down-regulate MHC-I molecules (B) what is called missing self or up-
regulate stress induced activating ligands (induced self) (C). Both situations result in an excess of 
activating over inhibitory signals what triggers the activation of the NK cell and the subsequent killing 
of the target cell. +, activating receptors; –, inhibitory receptors. The tilt of the balance indicates if the 
integration of the inhibitory and activating signals that NK cell receives upon target cell recognition 
leads to inhibition (tilt to the right) or activation (tilt to the left) of the NK cell. 
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A cell that is perturbed by viral infection or cellular transformation can either down-
regulate MHC-class I molecules and/or up-regulate stress-induced self molecules 
such as NKG2D ligands. This results in excessive NK cell activation and leads to the 
killing of the target cell (Karre et al., 1986; Vivier et al., 2004; Vivier et al., 2011).  
The lack of MHC class I on a target cell leads to an NK cell activation due to the loss 
of inhibitory signals. This phenomenon is named missing self-recognition. Conversely, 
induced self-recognition defines NK cell activation due to strong activating signals 
triggered by stress induced self-ligands. In this situation the strong activating signals 
override the inhibitory signals delivered by MHC class I molecules (Fig. 3) (Long et 
al., 2013; Poggi and Zocchi, 2014). 
Mouse NK cells express a variety of MHC class I–specific lectin-like Ly49 inhibitory 
receptors on their cell surface that function by signaling through intra-cytoplasmic 
immune-receptor tyrosine-based inhibition motifs (ITIMs) (Karlhofer et al., 1992; 
Vivier et al., 2004). Ly49 receptors are aquired during BM development in a 
stochastic, variegated and overlapping manner, and are involved in a process that 
has been referred to as 'NK cell education'. Mature NK cells that express at least one 
inhibitory NK cell receptor that is engaged by self-MHC-I molecules show full 
functional competence (Held, 2013; Held et al., 2011; Orr and Lanier, 2010; Raulet 
and Vance, 2006). NK cells that do not recognize MHC-I are hypo-responsive. 
However the Ly49 family of genes also encodes activating receptors like Ly49H, 
which recognizes the mouse cytomegalovirus (MCMV) protein m157 (Sun et al., 
2009). Indeed MCMV clearance is dependent on Ly49H NK cells (Biron et al., 1999). 
Other NK cell activating receptors like NKG2D detect self-molecules that are over-
expressed upon initiation of cellular distress (Raulet and Guerra, 2009; Smith et al., 
2002). Most NK cells express CD16 (FcγRIIIa), an activating low-affinity receptor for 
the Fc domain of IgG-isotype antibodies. Through CD16, NK cells recognize and kill 
antibody-coated cells, a process called antibody-dependent cell-mediated cytotoxicity 
(ADCC).  
NK cells start to express high levels of Perforin, GzmB and IFNγ mRNAs during their 
development in the bone marrow (Fehniger et al., 2007; Stetson et al., 2003). The 
trigger for the acquisition of this effector program during bone marrow maturation is 
currently not known, eventhough IL-17 may play a role (Bar et al., 2014). Although 
naïve NK cells constitutively express high levels of Perforin, GzmB and IFNγ mRNAs 
the translation into protein does not occur (Fehniger et al., 2007; Stetson et al., 2003).  
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The translation of preformed Perforin and GzmB mRNA into protein is dependent on 
NK cell priming by cytokines such as IL-15 (Lucas et al., 2007). Indeed, NK cells in a 
naïve mouse have poor cytotoxic activity. Early in an immune response, infected or 
activated pDCs can activate NK cells in a type I IFN-α/β–dependent manner (Miyagi 
et al., 2007; Schleicher et al., 2007). Activated dendritic cells and macrophages 
produce the cytokines IL-15 and IL-18 (Degli-Esposti and Smyth, 2005; Newman and 
Riley, 2007; Walzer et al., 2005). Dendritic cell–mediated IL-15 trans-presentation 
results in the translation of pre-existing Perforin and GzmB mRNA pools in the NK 
cell (Chaix et al., 2008; Fehniger et al., 2007; Gordon et al., 2012; Lucas et al., 2007; 
Stetson et al., 2003).   
NK cell killing of target cells is initiated by the pore-forming protein Perforin and 
executed by the Granzyme family of serine proteases (Held, 2013; Masson and 
Tschopp, 1987). Mice have 10 different Granzyme genes (A-G, K, M and N) that are 
localized in clusters on three different chromosomes.  
After expression, the mRNA is translated to a pro-GzmB, an inactive precursor 
protein that carries an N-terminal signal peptide to ensure the packaging into 
secretory granules. The cleaving of the dipeptide Gly-Glu at the N-terminus of pro-
GzmB by the cysteine protease cathepsin C generates the enzymatically active form 
of GzmB. The principal cytoplasmic inhibitor of GzmB is the serine protease inhibitor 
6 (Spi-6) (Ida et al., 2003; Laforge et al., 2006; Phillips et al., 2004; Zhang et al., 
2006). Spi-6 prevents the processing of the N-terminal pro-peptide by the protease 
cathepsin and thereby protects the NK cell from GzmB mediated self inflected 
apoptosis (Fig. 4). (Caputo et al., 1993; Pham and Ley, 1999; Sun et al., 1997; 
Zhang et al., 2006). 
Granzymes and Perforin are stored within secretory lysosomes were they are kept 
inactive by low pH and calcium concentrations. Upon target cell recognition lytic 
granules are polarized towards the immunological synapse, where they fuse with the 
plasma membrane. Their content is relased into the synaptic cleft between effector 
and target cell. Subsequently Granzmye B (GzmB) enters the target cells with the 
help of Perforin, and rapidly induces apoptosis via both, caspase-dependent and 
caspase-independent mechanisms. Perforin can either directly form pores in the 
phospholipid bilayer of target cells to facilitate entry of granzymes or alternatively 
disrupt the membranes of target-cell endosomes that contain Granzymes (Long et al., 
2013; Voskoboinik et al., 2006; Wang et al., 1996) (Fig. 4).  
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The second way by which killer cells induce apoptosis in target cells is via the 
expression of death ligands like TNF (tumour-necrosis factor), Fas-L and TRAIL 
(TNF-related apoptosis inducing ligand) that are recognized by death receptors on 
the target cell. This interaction activates caspase-mediated death pathways in the 
target cell (Lodolce et al., 1998; Suzuki et al., 1997).  
In addition to killing, NK cells produce inflammatory cytokines like INFγ, TNFα and 
GM-CSF or suppressive cytokines as IL–10 and TGFβ. Further they secrete 
chemokines, recruiting different effector cells (such as ATAC/lymphotactin, Mig, MIP-
1α and RANTES) (Fehniger et al., 2007; Lucas et al., 2007; McCartney et al., 2009; 
Russell and Ley, 2002).  
 
Figure 4. Target cell killing by NK cells. 
Following priming by cytokines, NK cells translate pre-formed mRNA for GzmB, INFγ and Perforin 
(small arrow within the NK cell). Subsequently, target cell recognition and activation triggers the 
polarization of lytic granules filled with GzmB and Perforin, towards the immunological synapse. 
There they fuse with the plasma membrane and release their contents into the synaptic cleft between 
the effector and the target cell. GzmB enters the target cells with the help of Perforin, and rapidly 
induces apoptosis via caspase-dependent and caspase-independent mechanisms. Pro-GzmB is an 
inactive precursor protein. Removal of a dipeptide at the N-terminus of pro-GzmB by the cysteine 
protease Cathepsin C generates the enzymatically active form of GzmB. The principal cytoplasmic 
inhibitor of GzmB is the serine protease inhibitor 6 (Spi-6). Spi-6 prevents the processing of Pro-
GzmB by the protease Cathepsin C. This mechanism protects the NK cell from GzmB mediated self 
inflected apoptosis. A process that we will discuss in detail in this thesis. 
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1.6 Cytokines in NK cell development and function 
The NK cell committed progenitors up-regulate the IL-15 receptor complex, 
consisting of the IL-15 receptor α (IL-15Rα), IL-2Rβ (CD122), and the IL-2 receptor 
common γ chains (IL-2Rγc). This receptor complex is making the progenitor cells 
responsive to IL-15, a cytokine necessary for NK development, survival and 
proliferation. Mice that lack IL-15 or its high affinity receptor (IL-15Rα) display 
dramatic defects in NK cell development and lack peripheral NK cells. Similar defects 
have been observed for mice lacking the activator for the transcription of STAT5 a 
downstream signaling component of the IL-15 receptor (Eckelhart et al., 2011; 
Kennedy et al., 2000; Suzuki et al., 1997). During homeostasis IL-15 plays a major 
role to ensure the survival and proliferation of peripheral NK cells, via the 
maintenance of the antiapoptotic factors Bcl-2 and Bcl-XL (Ranson et al., 2003). 
Developing NK cells express the cytokine receptor Fms-like tyrosine kinase-3 (FLT3). 
NK cell development and NK cell effector functions are impaired in mice that lack the 
Flt3 ligand (Cheng et al., 2009; McKenna et al., 2000). Recently it has been shown 
that IL-17Rα is expressed in NKPs and iNK cells, but not in the mNK cells in the BM. 
Mice that lack the IL17Rα have normal NK cell counts in the BM and spleen. Upon 
priming IL17Rα deficient NK cells up-regulate CD69 but they show a defect in their 
ability to produce IFNγ. Furthermore their cytotoxic activity towards YAC-1 target cells 
is strongly impaired. NK cells that develop in the absence of IL-17 are unable to clear 
the mouse cytomegalovirus (MCMV) (Bar et al., 2014). Thus IL-17Rα signalling in NK 
cell precursors is a crucial trigger for the aquisition of their effector potential. 
 
1.7 Transacting factors in NK cell development and 
function 
The maturation of NK cells is governed by different transcription factors. The 
interplay between these transacting factors is still poorly understood and additional 
factors are likely involved. In the following part some of the most important 
transcription factors involved in NK cell development and function are discussed (Fig. 
5 and 6). 
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Figure 5. Transcription factors in NK cell development. 
Arrows indicate the stages where the transcription factors play a crucial role. CLP, common lymphoid 
precursors, NKP, NK cell precursors; iNK, immature NK cell; mNK, mature NK cells (compare Fig. 2). 
 
 
Figure 6. Transcription factors in NK cell function. 
Indicated are the transcription factors that play an essential role for cytokine production or cytotoxicity 
during the process of target cell killing (compare Fig. 4). 
 
Introduction 
	   15	  
1.7.1 Ikaros 
The zinc finger transcription factor Ikaros is crucial for the differentiation of HSC into 
lymphoid progenitor cells and for their maintenance (Arranz et al., 2012; Yoshida et 
al., 2006). Ikaros-deficient mice do not express the cytokine receptor Flt3 and 
express reduced levels of the stem cell growth factor receptor c-kit. Ikaros-deficient 
precursors fail to express CD122, which is crucial for IL-15 responses. Consequently, 
Ikaros deficient mice do not possess fetal T, B and NK cells and are deficient for 
adult T cells and NK cells (Wang et al., 1996).  
 
1.7.2 Ets-family transcription factors: Ets-1, PU.1 and Mef 
The winged helix-turn-helix transcription factors Ets-1, PU.1 and the myocyte 
enhancer factor (Mef) play an important role for NK cell development during the NKP 
to iNK transition and beyond. Mature NK cells are strongly reduced and not functional 
in mice deficient for any of those transcription factors (Barton et al., 1998; Colucci et 
al., 2001). NK cell development in Ets-1 deficient mice is blocked at the iNK cell 
stage or earlier as BM mNK cells are absent. Ets-1 deficient NK cells are not able to 
kill target cells like RMAS or YAC (Barton et al., 1998). Mef-deficient NK cells have a 
defect in INFγ production. Furthermore, they express reduced levels of Perforin. Mef 
can bind to the Perforin locus and induce its expression. As a consequence the NK 
cells that lack Mef show strongly reduced effector functions. PU.1 deficient mice kill 
YAC-1 targets but are defective in their ability to proliferate. PU.1 deficient NK cells 
do not expand after IL-2 stimulation due to a cell intrinsic cell cycle defect (Barton et 
al., 1998; Colucci et al., 2001).  
 
1.7.3 Id proteins and repression of E-box proteins 
Id2 belongs to the inhibitor of DNA-binding (Id) protein family which contains a helix-
loop-helix (HLH) dimerization domain but lacks a basic DNA-binding domain. Id 
proteins can bind to E proteins that contain a basic DNA-binding region adjacent to a 
HLH dimerization domain and thereby prevent E proteins from binding to DNA and 
activating target genes (Kee, 2009). Regulation of the E and Id protein ratio allows 
the control of differentiation programs. In the absence of Id2, peripheral NK cells are 
strongly reduced and they have decreased effector function capability (Yokota et al., 
1999). The function of Id proteins in NK cell differentiation is to repress E proteins at 
the NKP and mNK stage. Over-expression of E proteins inhibits NK cell development 
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whereas the elimination of E proteins in Id2 deficient mice restored NK cell 
development. The role of Id proteins in NK cell precursors might be to suppress the 
expression of other lineage programs and thereby promote NK cell development (Ji 
et al., 2008; Quong et al., 2002).  
 
1.7.4 E4bp4 
The transcription factor E4-binding protein 4 (E4bp4), encoded by the Nfil3 gene, is 
highly expressed during the progression from the NKP to iNK and iNK to mNK stages 
(Gascoyne et al., 2009; Male et al., 2011). E4bp4-deficient mice have a severe NK 
cell deficiency whereas T and B cell numbers are normal. The NK cell development 
in E4bp4-deficient mice is blocked at the NKP to iNK transition with the consequence 
that the number of iNK and mature NK cells are drastically reduced (Gascoyne et al., 
2009; Kamizono et al., 2009). The NK cell differentiation defect is cell intrinsic, as 
differentiation was not rescued when E4bp4-deficient bone marrow was transplanted 
into irradiated wild-type recipients (Gascoyne et al., 2009; Male et al., 2011). NK cells 
that lack E4bp4 express lower levels of the activation receptors 2B4, Ly49D, and 
Nkp46 and the integrin CD11b. Moreover, they have a defect in their ability to 
produce INFγ and to kill target cells.  
E4bp4 induces the expression of inhibitor of DNA-binding 2 (Id2), which is essential 
for the subsequent iNK-mNK transition (see above). Reconstitution of E4bp4-
deficient mice with ectopically expressed Id2 restores the development of NK cells 
(Boos et al., 2007; Gascoyne et al., 2009; Yokota et al., 1999). Despite the near 
absence of NK cells, these mice do not manifest increased development of 
spontaneous cancers or other immune system disorders (Gascoyne et al., 2009). 
 
1.7.5  T-bet and Eomes 
T-bet deficiency leads to a reduction in the numbers of mNK cells. It has been shown 
that T-bet controls the repression of the immaturity markers CD27 and c-kit and the 
induction of CD43 and KLRG1 by NK cells. The lack of T-bet leads to a strong 
increase of iNK cell number in the bone marrow.  Peripheral NK cell numbers are 
strongly reduced with the exception of lymph nodes where the frequency of NK cells 
is elevated (Townsend et al., 2004). The altered distribution of NK cells relies on the 
fact that the absence of T-bet leads to a reduced expression of S1P5. S1P5 belongs 
to a receptor family that controls lymphocyte trafficking and governs the egress of NK 
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cells from BM and lymph nodes. S1P5 is a direct target of T-bet (Jenne et al., 2009). 
NK cells display increased basal rates of proliferation and apoptosis in the absence 
of T-bet. This might be an additional cause for the reduced numbers of NK cells 
found in the periphery. T-bet represses CD27 and c-kit and induces CD43 and 
KLRG1. Moreover, adult T-bet deficient mice lack a population of liver NK cells that 
expresses the death receptor TRAIL (DX5-TRAIL+) (Gordon et al., 2012).  
In contrast to T-bet deficient mice, where DX5+ mNK cells can develop, Eomes 
deficient mice lack mature NK cells that are defined by high expression of DX5. 
Further analysis revealed that bone marrow NK cell development is blocked at the 
iNK stage.  
In the absence of both, T-bet and Eomes, mice were nearly devoid of mature NK 
cells. Both lineages depend on IL-15 and it has been shown that T-bet and Eomes 
cooperate to induce high expression of CD122 (Gordon et al., 2012). Eomes and T-
bet double-deficient mice have a normal NKP population, however, they are not able 
to acquire the NK cell lineage markers NK1.1 and NKp46 and to differentiate into 
mature NK cells. Experiments with bone marrow chimeras have confirmed that the 
observed effects for T-bet and Eomes are cell intrinsic.  
A recent study suggests the existence of two alternative pathways of NK cell 
development occurring in the BM and in the liver. An Eomes-GFP reporter has 
shown that Eomes-GFP- NK cells preferentially home to the liver, whereas Eomes-
GFP+ NK cells mainly home to the spleen. Further experiments revealed that NK cell 
precursors in the bone marrow express low levels of T-bet, which allows their 
development into mature Eomes+Trail- NK cells. Reciprocally, the liver environment 
permits high expression of T-bet early during NK cell development, which results in 
Eomes repression and instructs the development of Eomes− Trail+ DX5− Itga1+ NK 
cells. These NK cells mainly produce the cytokines IL-2 and TNF and may have 
specific immunoregulatory functions that are crucial for the local protection of the liver. 
The mutually exclusive expression of T-bet and Eomes in NK cell precursors is 
thought to drive NK cell lineages with complementary functions (Daussy et al., 2014).  
In the absence of T-bet, susceptibility to metastatic cancer, including melanoma is 
increased. Most likely this is due to the combined effects of reduced cytotoxicity, 
homing ability and IFNγ production (Werneck et al., 2008). However T-bet-deficient 
NK cells still are able to express some INFγ and Perforin and they are only mildly 
defective in killing target cells (Aberle et al.).  
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1.7.6 GATA-3 
The zinc-finger transcription factor GATA-3 binds the consensus (A/T)GATA(A/G) 
motif and can activate or repress transcription. Peripheral NK cell counts in the 
spleen and the blood of GATA-3 deficient mice are normal but hepatic and thymic 
CD127+ NK cells do not develop (Samson et al., 2003). GATA-3 plays a crucial role 
during the final maturation of mNK cells. In the absence of GATA-3, mNK cells 
expand normally but they show reduced expression of the maturation markers 
CD11b, CD43 and KLRG1. GATA-3 deficient NK cells show normal target cell killing. 
However they have a reduced ability to produce INFγ (Samson et al., 2003). 
 
1.7.7 Runx proteins 
The transcription factor Runt-related transcription factor 3 (Runx3) and its binding 
partner Core-binding factor subunit β (CBFβ) are expressed during the NK cell 
development from the NKP stage onwards. CBF can both, activate and repress 
target genes by forming complexes with other transcription factors and by recruiting 
histone acetyltransferases and histone deacetylases. Mice deficient for Runx3 are 
embryonically lethal. Ohno et. al. produced transgenic (Tg) mice that express the 
Runt domain under the control of the CD2 promoter. In contrast to the full-length 
Runx the truncated form Runt contains the domain for both DNA binding and hetero-
dimerization with CBFβ, but lacks the trans-activating domain. This dominant 
negative form binds with a higher affinity to CBFβ and the DNA target sequence than 
to full-length Runx proteins. Mature NK cells in transgenic mice showed reduced 
expression of the maturation markers CD11b and CD43 and of the Ly49 receptors. 
IFNγ production was greatly enhanced in these mice. They show normal cytotoxicity 
against YAC-1 target cells. Knock-in mice that express Runx3 together with a 
fluorescent protein showed expression from the NKP stage onwards (Levanon et al., 
2014; Ohno et al., 2008). 
 
1.7.8 IRF-2 
The interferon regulatory factor (IRF) plays an important role for the survival of mNK 
cells in the bone marrow. In IRF-2 deficient mice DX5+ NK cells are generated, but 
they fail to acquire CD11b and to expand due to accelerated apoptosis. As a 
consequence the peripheral NK cell numbers are strongly reduced. However these 
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NK cells do not show a defect in cytotoxicity and they express normal levels of the 
Ly49 receptor (Lohoff et al., 2000; Taki et al., 2005). 
 
 
1.8 Tcf/Lef transcription factor family  
Our laboratory has discovered that peripheral NK cell numbers are reduced in the 
absence of T cell factor-1 (Tcf-1) (Held et al., 1999). This suggests a role for this 
trans-acting factor in NK cell development. In vertebrates the Tcf/Lef family 
comprises 4 members: Lef-1, Tcf-1 (Tcf7), Tcf-3 and Tcf-4 (Arce et al., 2006; 
Archbold et al., 2012). Tcf-1 was discovered as a T-cell-specific transcription factor 
that binds to the CD3ϵ enhancer (Oosterwegel et al., 1991b). Lef-1 was cloned from 
early B cells by a subtraction strategy and was shown to bind and activate the T-cell 
receptor α enhancer (Travis et al., 1991; Waterman et al., 1991). Tcf-1 and Lef-1 
contain a HMG (high mobility group) box (van de Wetering et al., 1991), which binds 
a specific DNA sequence in the minor groove of the double helix. Like other HMG 
box-containing transcription factors Tcf-1 and Lef-1 enforce a bend between 90° and 
127° in the DNA helix facilitating the formation of large nucleoprotein complexes 
(Giese et al., 1995; Love et al., 1995). Tcf-1/Lef-1 possess no intrinsic ability to 
modulate transcription but are usually associated with a transcriptional repressor 
(Groucho (Gro) in Drosophila, Groucho-related gene in mouse or transducin-like 
enhancer protein in humans) that is bound to a central domain of Tcf-1/Lef-1 and 
inhibits the expression of target genes (Cavallo et al., 1998). A long isoform of Tcf-1 
(termed p45), which is transcribed from a distal promoter, contains a β-catenin 
interaction domain at its N-terminus. Association with β-catenin leads to replacement 
of Gro and the transcriptional activation of target genes. The short isoform of Tcf-1 
(termed p33) is transcribed from a proximal promoter, lacks the β -catenin binding 
domain and may have dominant-negative effects (Fig. 7). In postnatal mice Tcf-1 is 
mainly expressed by lymphoid cells and regulates the survival, proliferation and 
differentiation of these cells (Ioannidis et al., 2001; Reya et al., 2003; Verbeek et al., 
1995). Tcf-1 is highly expressed in T cells, innate lymphoid cells and NK cells 
whereas Lef-1 is expressed by T cells and by pre-B cells. 
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Figure 7. Different isoforms of Tcf-1 
Shown are the Tcf-1 isoforms named p33 and p45. They derive from alternative promoter usage and 
alternative splicing. Both isoforms contain a HMG (high mobility group) box (grey), which binds DNA 
via a specific consensus sequence and a central Groucho binding domain (red). The Tcf-1 isoforms 
possess no intrinsic ability to modulate gene transcription but they are usually associated with 
Groucho that represses target genes. The long p45 isoform of Tcf-1 contains a β/γ-catenin interaction 
domain at the N-terminus (green). Binding of β/γ-catenin to the N-terminus of p45 leads to the 
replacement of Groucho and the activation of Wnt target genes. 
 
1.9 The canonical Wnt pathway 
Tcf/Lef are nuclear effectors of the canonical Wnt signaling pathway.  Wnt signaling 
is initiated by secreted lipid-modified glycoproteins called Wingless/Integration-1 
(Wnt) (Willert et al., 2003) that bind to a cell surface receptor complex composed of 
the frizzled receptor (Fz) together with the lipoprotein receptor-related proteins LRP6 
and LRP5. In the absence of a Wnt ligand β-catenin is sequestered in a multi-protein 
complex and phosphorylated by the glycogen-synthase kinase 3 β (GSK3β). 
Phosphorylated β-catenin is subsequently ubiquitinylated by the β-transducin-repeat-
containing protein (β-TRCP) and targeted for proteosomal degradation. In contrast, 
the binding of a Wnt ligand to the Fz/LRP receptor leads to the disruption of the β-
catenin degradation complex (Mao et al., 2001a; Mao et al., 2001b; Tolwinski et al., 
2003). Consequently β-catenin is stabilized and can translocate to the nucleus, 
where it binds to the N-terminus of the Tcf/Lef family members  (Fig. 8). This 
association induces the transient transcription of Tcf/Lef target genes such as c-myc, 
cyclin D1 and Axin2 (conductin) (Kikuchi et al., 2006).  
The canonical Wnt signaling pathway play essential roles during embryonic 
development especially for the body axis formation and for the development of the 
mesoderm that gives rise to the hematopoietic system. Furthermore, this pathway is 
critically involved in the maintenance of self-renewing tissues including the skin, the 
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gut, hair follicles and hematopoietic stem cells. Aberrant or constitutive Wnt signaling 
is the cause of various cancers like colon cancer (see below) (Reya and Clevers, 
2005).  
 
 
Figure 8. Canonical Wnt pathway.  
(A) When Wnt is not present, β-catenin is phoyphorylated by a complex formed by adenomatous 
polyposis coli (APC), glycogen-synthase 3β (GSK3β), Axin and other proteins. Subsequently β-catenin 
is tagged with ubiquitin for proteasomal degradation. The nuclear effector of canonical Wnt signaling 
Tcf-1 is associated with Groucho (Gro) what leads to target cell repression. (B) Wnt binding to its 
receptors low-density-lipoprotein-receptor related protein 5/6 (LRP5/6)/Frizzled results in the 
inactivation of GSK3 by Dishevelled (Dvl). Stabilized β-catenin migrates to the nucleus where it binds 
to the N-terminus of Tcf-1 in order to activate target genes. 
 
1.10 The Wnt pathway and cancer  
Constitutive activation of the Wnt signaling pathway due to mutations in the multi-
domain protein APC or β-catenin is a hallmark of colon cancer. In the absence of Wnt 
signaling, APC together with GSK-3β target β-catenin for degradation by the 
proteasome. However in APC or β-catenin mutant colon cells, degradation is 
disrupted and levels of free β-catenin rise dramatically. Free β-catenin can 
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translocate to the nucleus, where it engages DNA-bound Tcf/Lef transcription factors 
by binding to the N-terminus. This leads to the replacement of the repressor Groucho 
(Gro) and the constitutive activation of genes involved in proliferation and/or in 
antagonizing apoptosis (Korinek et al., 1997; Morin et al., 1997; Rubinfeld et al., 
1997) (Figure 8, above).  
Furthermore, the removal of Tcf7 leads to the development of adenomas in the gut 
and mammary glands of mice. Moreover Tcf7 deficient mice develop thymomas that 
are characterized by high Lef-1 mRNA expression. In colon cells the isoform of Tcf-1 
that is lacking the β-catenin interaction domain is expressed at much higher levels 
than the full-length form of Tcf-1. It has been suggested that the loss of the short Tcf-
1 isoform is the cause for the development of adenomas in the gut and mammary 
glands of Tcf7 defidient mice (Roose et al., 1999). Thus Tcf-1 might also function as 
a tumor suppressor. 
 
1.11 Role of Tcf-1 and the Wnt pathway for lymphocyte 
development and function 
A Tcf-1 deficiency results in partial blocks at multiple stages of T cell development. 
These T cell development stages can be followed by the sequential expression of cell 
surface markers: the double negative (DN)1 (CD4−CD8−CD44+CD25-) to the DN2 
(CD4−CD8−CD44+CD25+) transition, the DN3 (CD4−CD8−CD44-CD25+) to DN4 (CD4-
CD8-CD44-CD25-) transition as well as the immature single positive (ISP) to the 
double positive CD4+CD8+ (DP) transition (Goux et al., 2005; Ioannidis et al., 2001; 
Jeannet et al., 2008b; Schilham et al., 1998; Verbeek et al., 1995).  The 
developmental blocks caused by Tcf-1 deficiency coincide with stages of extensive 
cell proliferation (DN2 and DN4). Thymocytes lacking Tcf-1 normally produce and 
express a functional pre-T cell receptor (TCR). Subsequently Tcf7 deficient DN3 cells 
proliferate efficiently, however icTCRβ+ DN4 cells do not accumulate due to rapid cell 
death (Goux et al., 2005). DP cells of Tcf-1 deficient mice undergo accelerated cell 
death due to reduced levels of the anti apoptotic molecule Bcl-xL. Even though the 
survival of DP thymocytes was rescued in Bcl-2−Tg Tcf7-/- mice, the thymus 
cellularity did not improve (Ioannidis et al., 2001). The -catenin/Tcf-1 pathway 
enhances DP thymocyte survival in a RORγt-dependent manner (Wang et al., 2011). 
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The -catenin/Tcf-1 acts genetically upstream of the transcription factor RORγt that 
up-regulates Bcl-xL to increase the lifespan of DP cells (Sun et al., 2000; Xie et al., 
2006). Taken together, Tcf-1 is required for the survival of proliferation of thymocytes 
at the preTCR stage and for the survival of differentiating DP thymocytes. The 
mechanims through which Tcf-1 regulates these processes might be different. A 
genetic complementation approach showed that the N-terminal β-catenin-binding 
domain of Tcf-1 (amino acids 1-117) was required to rescue thymocyte development 
in Tcf7 deficient mice (Ioannidis et al., 2001). Importantly, T cell development is 
normal in the combined absence of β- and γ-catenin (Cobas et al., 2004; Jeannet et 
al., 2008b; Koch et al., 2008). That suggests the existence of either an additional Wnt 
independent role for Tcf-1 or the presence of an additional transmitter of canonical 
Wnt signals. Indeed it has been suggested that the transcription factor activating 
transcription factor 2 (ATF2) can mediate Wnt signaling in leukemia and in lymphoma 
cells by associating with the N-terminus of Tcf-1 and Lef-1 (Grumolato et al., 2013). 
The expression of Tcf-1 is strongly induced upon activation of Notch signaling in 
early thymic progenitors (ETP) and Tcf-1 subsequently drives the T cell specification 
(Germar et al., 2011; Weber et al., 2011).  
 
1.11.1 Role of Tcf-1 in innate lymphoid cell development 
Tcf-1 is essential for the development and/or the differentiation of several innate 
lymphocyte subsets including NK cells, ILC2 and NKp46+ ILC3 (Held et al., 2003; 
Mielke et al., 2013; Yang et al., 2013), innate lymphocytes that lack Ag-receptors but 
functionally match subsets of T helper cells (Spits and Cupedo, 2012). As 
mentionned above Tcf-1 deficiency results in a reduced number of peripheral NK 
cells (Held et al., 2003; Held et al., 1999). NK cells, LTis and ILC share a common 
progenitor (IL-7Rα+α4β7high) but the subsequent lineage specific developmental 
commitment is distinct. Tcf-1 expression in ILC2 and NKp46+ ILC3 seems to be 
Notch dependent (Lee et al., 2012; Ribeiro et al., 2010). There is no evidence for a 
role of Notch in NK cell development (Ribeiro et al., 2010). Thus the exact role of Tcf-
1 for NK cell development remains to be defined.  
 
1.11.2 Role of Tcf-1 in T cell function  
CD8+ T cells lacking Tcf-1 mount a normal primary response to infection with 
lymphocytic choriomeningitis virus (LCMV). However, CD8+ LCMV immune T cells 
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from Tcf-1-/- mice fail to expand upon secondary infection. Thus Tcf-1 is essential for 
the generation of functional CD8 T cell memory. A corresponding defect is observed 
in the absence of β- and γ-catenin, suggesting that memory formation depends on 
Tcf-1 function in the context of the Wnt pathway (Jeannet et al., 2010). Furthermore it 
has been shown that Tcf-1 and β-catenin positively regulate GATA-3 expression in 
TCR-activated CD4+ T cells. This led to an increased IL-4 production by these 
activated T cells resulting in the subsequent polarization into T helper type 2 (Th2) 
cells (Yu et al., 2009). A further a role for Wnt/β-catenin signaling in mature T cells is 
demonstrated by experiments using CD4+CD25+ regulatory T (Treg) cells that have 
been transduced with stable β-catenin. These cells survived longer in vitro and 
outcompeted control Treg cells in vivo (Ding et al., 2008). Endothelial cell derived 
Wnt proteins have been shown to mediate the up-regulation of matrix 
metalloproteinase 2 (MMP2) and MMP9 in effector T cells and increase T cell 
transmigration. This process could be inhibited in vitro and in vivo by a soluble form 
of the Wnt receptor Fz5 (sFz5-Fc) (Wu et al., 2007). Further Tcf-1 is required to 
epigenetically maintain the IL-17 gene locus in a repressed state. In the absence of 
Tcf-1 the chromatin of the IL-17 locus is less dense, resulting in a high potential for 
differentiation of T cells into Th-17 cells (Ma et al., 2011). Taken together these 
studies show that Tcf-1 plays an essential role to modulate T cell function.  
 
1.12 Aim  
The transcriptional network that controls NK cell development and function is 
incompletely understood. The aim of my thesis was to define whether Tcf-1 plays a 
role in NK cell development, homeostasis and/or function and to determine whether 
Tcf-1 acts in the context of the canonical Wnt signaling pathway to mediate some or 
all of its functions. Taken together the aim of my thesis was to obtain novel insights 
into the control of the development and the function of NK cells. 
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2 Results 
2.1 Canonical Wnt signaling and Tcf-1 expression during 
NK cell development  
The first aim was to test if and when the T cell factor-1 (Tcf-1, encoded by the Tcf7 
gene) is expressed during natural killer (NK) cell development and if we can detect 
Wingless/Integration-1 (Wnt) signal transduction. By intracellular FACS we could not 
detect Tcf-1 expression in the NK cell precursor (NKp) cells. However Tcf-1 was 
abundantly expressed in immature NK (iNK) cells and slightly less in mature NK 
(mNK) cells compared to Tcf7-/- controls (Fig. 9A). The lymphoid enhancer factor-1 
(Lef-1) was absent in all three developmental stages (Fig. 9B). Furthermore, we 
detected Tcf-1 in a subset of splenic NK cells from naïve mice whereas Tcf-1 levels 
were reduced in NK cells from Polyinosinic:polycytidylic acid (Poly IC) primed mice 
(Fig. 9C). Lef-1 was absent in naïve and primed NK cells (Fig. 9D). Therefore we 
conclude that during bone marrow development Tcf-1 levels peak at the iNK stage 
and are maintained in mNK cells. Upon activation by Poly IC the Tcf-1 levels 
decrease. 
To determine whether NK cells receive canonical Wnt signals during development, 
we measured the expression of conductin/axin2. Conductin is induced in response to 
Wnt signals (Jho et al., 2002; Lustig et al., 2002). Moreover, conductin is a direct Tcf-
1 target in CD8+ T cells (Zhou et al., 2010). We used mice in which the endogenous 
open reading frame of one conductin allele was replaced with a bacterial β-
galactosidase reporter gene (termed conductinLacZ). Β-galactosidase activity was 
used to measure Wnt signal transduction at the single cell level ex vivo. While we 
detected significant β-galactosidase activity in T cells but not in B cells (Fig. 10A), we 
failed to detect conductin expression in NKp cells. We detected strong reporter 
activity in the iNK population and maintenance of the signal in a subpopulation of 
mNK cells (Fig. 10B). Similar to bone marrow (BM) mNK cells, we detected 
significant β-galactosidase activity in a subset of splenic NK cells (Fig 10A and B). 
Importantly the conductin signal was entirely dependent on Tcf-1 both in splenic as 
well as in BM mNK cells (Fig. 10B). Concordant with Tcf-1 expression, Wnt signaling 
Results 
	  26	  
is induced during the NKp to iNK transition and is maintained in a subpopulation of 
mNK cells. 
 
 
Figure 9. Tcf-1 is expressed in developing and mature NK cells. 
In A and B it was gated on BM NKp (CD3-IL-2/15Rβ+NK1.1-DX5-), iNK (CD3-IL-2/15Rβ+NK1.1+DX5-) 
and mNK (CD3-IL-2/15Rβ+NK1.1+DX5+) cells and in C and D on splenic NK cells (CD3-NK1.1+). 
Histograms show Tcf-1 (A and C) or Lef-1 expression (B and D) in Tcf7+/+ NK cells (black line) as 
compared to controls (filled grey)  (i.e.Tcf7-/- NK cells in A and C and isotype controls in B and D. 
Histograms in C and D depict Tcf-1 (C) or Lef-1 (D) expression in either naïve (upper row) or Poly IC 
primed  (lower row) splenic Tcf7+/+ NK cells (CD3-NK1.1+) as compared to controls (filled grey)  
(i.e.Tcf7-/- NK cells in C and an isotype control D. 
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Figure 10. Wnt signal transduction in NK cells 
A. Histograms show β-galactosidase (conductinLacZ) activity in gated T, B and NK cells in the spleen. 
Overlays represent background staining using conductin+/+ cells (grey shad) as compared to the 
signal obtained using cells form conductin+/LacZ cells (black line) B. Histograms show conductinLacZ 
expression in splenic NK CD3- NK1.1+ cells and in bone marrow NKp (IL-2/15Rβ+CD3-DX5+NK1.1-), 
iNK (IL-2/15Rβ+CD3-DX5+NK1.1-) and mNK (IL-2/15Rβ+CD3-DX5+NK1.1+) cells. Overlays represent 
background staining using Tcf7+/+ conductin+/+ cells (grey shad) as compared to Tcf7+/+ conductin+/LacZ 
cells (black line) and Tcf7-/- conductin+/LacZ cells (red line). Numbers indicate the mean fluorescence 
intensity (MFI) of LacZ staining of the indicated populations of cells.  Shown is one representative 
experiment out of at least 3. 
 
 
2.2 An essential role of Tcf-1 for NK cell development  
Based on the finding that Tcf-1 is strongly expressed during the iNK to mNK 
transition we next addressed whether NK cell development is affected by the loss of 
Tcf-1. Detailed analyses of hematopoiesis and lymphopoiesis showed that Tcf7-/- 
mice harbor a normal LSK (lineage- Sca-1+ c-Kit+) compartment, which includes 
hematopoietic stem cells (HSC). In addition, the number of CLPs (Common 
Lymphoid Progenitors, lineage- c-Kit+ IL-7Rα+) is not altered (not shown). The 
number of NKp and iNK cells was not significantly different as compared to control 
mice. In contrast, mNK cell numbers were considerably reduced (7 fold) in Tcf7-/- as 
compared to control mice (Fig. 11A and D) as reported earlier (Held et al., 1999; 
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Ioannidis et al., 2003). Splenic and liver NK cells were decreased 3 fold (Fig. 11 B, C 
and E). Taken together, we found that Tcf-1 deficiency partially blocks NK cell 
development at the mNK stage. 
 
 
Figure 11. NK cell development in the absence of Tcf7.  
Density plots of Tcf7+/+ and Tcf7-/- BM (A), spleen (B) and liver (C) cells stained for the indicated 
markers. Numbers indicate the percentage of gated cells (for the left panel of A, the panels B and C 
the numbers are the percentage of total cells; for the right panel of A numbers are the percentage of 
gated IL-2/15Rβ +CD3- cells). D and E. Numbers of cells of the indicated population in the BM (D) and 
spleen (E) of Tcf7+/+ and Tcf7-/- mice. D. Bar graphs represent the mean number of NKp, iNK and 
mNK cells in one hind leg ± SEM of n=10 mice.  The statistical significance of differences was 
calculated using two-tailed t-test and (*), (**) and (***) show significant differences (p<0.05), (p<0.01) 
and (p<0.001) respectively, compared to Tcf7+/+ mice. When nothing is marked, the values are not 
significantly different (p>0.05). 
 
2.3 A cell intrinsic role for Tcf-1 in NK cell development 
To address the basis for the impaired NK cell development in the absence of Tcf-1, 
we next determined whether NK cell development depends on Tcf-1 expression by 
NK cells or by the surrounding cells. Lethally irradiated wild type (wt) recipient mice 
(CD45.1+) were reconstituted with a mixture of equal proportions of Tcf7-/- (CD45.2+) 
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and wild type (CD45.1+) BM cells. Mixtures of Tcf7+/+ (CD45.2+) and wild type 
(CD45.1+) BM cells served as controls. After stable engraftment, chimeric mice were 
analyzed for the contribution of CD45.2+ cells to the NK cell compartment. As 
expected, a sizeable CD45.2+ NK cell population was detected in the spleen and BM 
of control chimeras receiving Tcf7+/+ BM (Fig. 12A, B and C). In contrast, very few 
CD45.2+ splenic or BM NK cells were derived from Tcf-1-deficient BM precursors (Fig. 
12A and B). Compared to controls, absolute numbers of Tcf7-/- NK cells per spleen 
and BM were reduced approximately 10 and 15 fold, respectively (Fig. 12C).  
 
 
 
Figure 12. Cell intrinsic role of Tcf-1 for NK cell development. 
Spleens from mixed BM chimeras were analyzed 2-3 months after reconstitution with a 1:1 mixture of 
competitor wt (CD45.1) and tester Tcf7+/+ (CD45.2) or wt (CD45.1) and Tcf7-/- (CD45.2) BM cells.  
Density plots show spleen cells stained with mAbs to CD45.1 and CD45.2. Gated CD45.1-CD45.2+ 
populations were analyzed for CD3 versus B220 expression (A) or CD3 versus NK1.1 expression in 
spleen or BM (B). Numbers indicate the percentage of cells in the respective region. (C) The bar 
graph shows the mean absolute number (±SD) of CD45.2+ cells per spleen in mixed chimeras of the 
indicated type. Data are derived from 8 – 10 chimeras.   
 
Contribution: 
Experiments shown in Figure 12. were performed and analyzed by Werner Held.  
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T cell development from Tcf-1-deficient BM precursors was similarly impaired, in 
agreement with a previous report (Weber et al., 2011). In contrast, the development 
of other hematopoietic lineages such as B cells, dendritic cells (CD11c+ MHC class 
II+) (Ferrero et al., 2002), Macrophages (CD11b+), Granulocytes (Gr-1+) and 
nucleated erythroid cells (Ter119+) were not dependent on Tcf-1 (data not shown). 
These data show that NK cell development depends on Tcf-1 expression by NK cells 
and not by the surrounding cells. Indeed, Tcf-1-deficient hosts readily supported NK 
cell development from Tcf-1 sufficient BM progenitors (W. Held, unpublished data). 
Overall these data show that Tcf-1 ensures NK cell development in a cell 
autonomous fashion. 
 
2.4 Normal NK cell development in the combined absence 
of β- and γ-catenin 
Although Tcf-1 binds DNA, it lacks intrinsic transcriptional activity. Tcf-1 represses 
target genes via its association with Groucho co-repressors. Target gene activation in 
response to Wnt signals depends on the binding of the co-activators β-catenin and γ-
catenin to the N-terminus of Tcf-1 (Grigoryan et al., 2008; Jeannet et al., 2008a). We 
analyzed NK cell development in mice lacking both β− and γ-catenin. Mice that have 
a null mutation of β-catenin or γ-catenin are embryonic lethal (Huelsken et al., 2000; 
Ruiz et al., 1996). Therefore we crossed mice harboring floxed alleles of β catenin 
(Huelsken et al., 2001) and γ-catenin with mice expressing Cre recombinase under 
the control of the hematopoietic-specific Vav regulatory elements (Katzav et al., 
1989; Ogilvy et al., 1999; Stadtfeld and Graf, 2005). We found that BM NK cell 
numbers and their developmental progression are normal in the combined absence 
of β-catenin and γ–catenin (Fig. 13A). Splenic NK cells were also normal (Fig. 13A).  
BM and splenic NK cells showed normal expression of maturation markers and of 
common inhibitory and activating receptors (data not shown). Moreover, the 
expansion of NK cells in response to IL-2 was normal in the combined absence of β-
catenin and γ-catenin (Fig. 13B). Overall these data show that β-catenin and γ– 
catenin are dispensable for NK cell development.  
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Figure 13. NK cell development is normal in the absence of β  and γ  catenin.  
(A) Density plots of β+/+ and γ-/- BM (left) and spleen cells (right) stained for the indicated markers. 
Numbers indicate the percentage of gated cells (for BM left panel and the spleen panel, numbers are 
the percentage of total cells, whereas for the BM right panel numbers are the percentage of gated IL-
2/15Rβ +CD3- cells). Bar graphs represent the mean number of NKp, iNK and mNK cells in one hind 
leg (left) and splenic NK cells (right) ± SEM of n=4 mice. (B) Nylon wool non-adherent splenocytes 
were labeled with CFSE and stimulated with IL2 for 5 days. Numbers indicate the percentage of cells 
in the indicated gates. These data are representative of 4 experiments. Bar Graphs show the fold 
expansion of NK cells after 5 days of stimulation + SEM. The statistical significance of differences 
was calculated using two-tailed t-test and (*), (**) and (***) show significant differences (p<0.05), 
(p<0.01) and (p<0.001) respectively, compared to Tcf7+/+ mice. When nothing is marked, the values 
are not significantly different (p>0.05).  
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2.5 The repressor domain in Tcf-1 mediates NK cell 
development  
While Tcf-1 was crucial for NK cell development, the two known Wnt signaling 
transmitters β-catenin and γ-catenin were dispensable. Thus we next tested whether 
the N-terminal catenin-binding domain of Tcf-1 was needed for NK cell development. 
To study the role of different domains of Tcf-1 for NK cell development, our 
laboratory has used a genetic complementation approach. A Tcf-1 transgene (Tg) 
containing the catenin-binding domain plus the repressor domain (p45) rescued T 
cell development in Tcf7-/- mice while a Tg containing only the repressor domain 
(p33) failed to do so (Ioannidis et al., 2001). We used the same approach to 
determine the mechanism of Tcf-1 function in NK cell development. Intriguingly, BM 
NK cell development is fully restored in p33 and in p45 Tg Tcf7-/- mice (Fig. 14). In 
addition, the splenic NK cell compartment was restored to normal in the p33 and the 
p45 Tg Tcf7-/- mice (Fig. 15). Data shown in Fig. 14 and 15, will be discussed in more 
detail later on. These data show that the short Tcf-1 isoform (p33), that contains the 
DNA- and Groucho-binding domains but lacks the β-catenin interaction site 
(Oosterwegel et al., 1991a; Van de Wetering et al., 1996), is sufficient to restore NK 
cell development.  
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Figure 14. The repressor domain of Tcf-1 mediates BM NK cell development. 
(A) Shown are dot plots of Tcf7+/+, Tcf7-/-, p33 Tcf7-/-, p45 Tcf7-/- BM cells stained for the indicated 
markers. Numbers indicate the percentage of gated cells (for A left panel, numbers are the percentage 
of total cells whereas for the right panel of A numbers are the percentage of gated IL-2/15Rβ +CD3- 
cells). Histograms and density plots show Ly49A, GzmB, KLRG1, CD11b and CD27 expression in 
gated mNK (IL-2/15Rβ +CD3-NK1.1+DX5+) cells. Numbers indicate the percentage of gated cells and 
the mean fluorescence intensity (MFI) of GzmB staining. Shown is one representative experiment out 
of four independent experiments. Bar graphs show the mean number of NK cells in one hind leg ± 
SEM of n=4 mice (B). (C) The graph depicts the relative mean fluorescence intensity (MFI) ±SEM of 
Granzyme B expression in GzmB-/-, Tcf7-/-, p33 Tcf7-/-, p45 Tcf7-/- mNK cells normalized to Tcf7+/+ 
controls that were set to 100%. (n=4). Based on the two-tailed t-test (*), (**) and (***) depict significant 
differences (p<0.05), (p<0.01) and (p<0.001) respectively, compared to Tcf7+/+ controls. When nothing 
is marked, the values are not significantly different (p>0.05). 
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Figure 15. The repressor domain of Tcf-1 restores the splenic NK cell compartment 
Shown are dot plots of Tcf7+/+, Tcf7-/-, p33 Tcf7-/-, p45 Tcf7-/- spleen cells stained for CD3 versus 
NK1.1. Numbers indicate the percentage of gated cells. Histograms and density plots show Ly49A, 
GzmB, KLRG1, CD11b and CD27 expression in gated NK (CD3-NK1.1+) cells. Numbers indicate the 
percentage of gated cells and the mean fluorescence intensity (MFI) of GzmB staining. Shown is one 
representative experiment of at least four independent experiments. (B) Bar graph represent the 
mean number of NK cells in the spleen ± SEM of n=4 mice. (C) The graph depicts the MFI ±SEM of 
GzmB expression in GzmB-/-, Tcf7-/-, p33 Tcf7-/-, p45 Tcf7-/- NK cells normalized to Tcf7+/+ controls 
that were set to 100%. (n=4). (D) The bar graph represents the fold expansion of Tcf7+/+, Tcf7-/-, p33 
Tcf7-/-, p45 Tcf7-/- NK cells between day 0 and day 5 of IL-2 stimulation (n=5). (E) The graph depicts 
the MFI ±SEM of GzmB expression in GzmB-/-, Tcf7-/-, p33 Tcf7-/-, p45 Tcf7-/- NK cells at day 5 of IL-2 
stimulation normalized to Tcf7+/+ controls, that were set to 100% (n=5). Based on the two-tailed t-test 
(*), (**) and (***) depict significant differences (p<0.05), (p<0.01) and (p<0.001) respectively, 
compared to Tcf7+/+ controls. If nothing is marked, the values are not significantly different (p>0.05). 
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2.6 Basis for impaired NK cell development in the absence 
of Tcf-1 
During their development in the BM, NK cells up-regulate the IL-15 receptor complex 
followed by inhibitory and activating surface receptors and finally maturation markers. 
The next aim was to define the basis for impaired NK cell development in the 
absence of Tcf-1. We first tested whether Tcf7 deficiency altered the expression of 
activating receptors, which control NK cell function upon interaction with ligands on 
target cells. We could not detect any significant changes in the expression levels of 
NKG2D, NKp46, NK1.1 or CD16 in BM or spleen NK cells in the absence of Tcf-1 
(Fig. 16A and B and data not shown). We also could not detect any significant 
changes in the expression levels of the signaling lymphocyte activation molecule 
(SLAM) family receptors (SLAM, 2B4, CD84, Ly-9, Ly-108 and CD2-like receptor 
activating cytotoxic cells (CRACC)) in mNK or splenic NK cells in the absence of Tcf-
1 (Fig. 16A and B). 
 
Figure 16. Activating receptors are normally expressed in the absence of Tcf-1. 
Histograms in show overlays of Tcf7+/+ (black line) and Tcf7-/-  (filled grey) mNK (CD3-IL-
2/15Rβ+NK1.1+DX5+) cells (A.) or splenic NK cells (CD3-NK1.1+) (B). Shown is the expression of 
different activating receptors including various SLAM family members.  
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NK cells also acquire receptors for major histocompatibility complex (MHC) class I-
molecules including CD94 /NKG2A, and Ly49 receptors. The Ly49 receptor family 
includes both inhibitory (Ly49A, Ly49C/I, Ly49F, Ly49G2, Ly49I) and activating 
receptors (Ly49D and Ly49H). The expression of Ly49D is significantly decreased 
wherease the expression of Ly49H, which recognizes the mouse cytomegalovirus 
(MCMV) protein m157, is normal in the absence of Tcf7 (Table 1). Our group has 
previously shown that the Ly-49a gene is a direct Tcf-1 target and that the Ly49A 
receptor is essentially absent in the absence of Tcf7 (Held et al., 1999).  Expression 
of the Ly49A receptor in Tcf7-/- NK cells is fully and partially restored by the p45 and 
the p33 Tgs, respectively (Ioannidis et al., 2003). The expression of the inhibitory 
Ly49 receptors (Ly49C/I, Ly49G2 and Ly49I) was not affected by the loss of Tcf7, 
whereas expression of the Ly49F, NKG2/ CD94 were decreased (Table 1). Thus, 
expression of several inhibitory receptors was decreased in the absence of Tcf-1.  
 
Table 1. Expression of Ly49 and CD94/NKG2 receptors.  
 
Shown is the Mean % + SD of different inhibitory and activating Ly49 family receptors and 
CD94/NKG2 expressed by splenic NK cells of the indicated genotypes. Red numbers indicate p>0.05 
vs B6. Black numbers indicate no significant difference from B6 controls.  
Contribution: 
This table was adapted and completed based on data provided by Werner Held. 
 
We next tested whether the loss of Tcf-1 had an impact on NK cell maturation. The 
iNK-mNK cell transition is associated with up-regulation of CD11b followed by CD43 
(Kim et al., 2002; Rosmaraki et al., 2001). We found that Tcf7-/- mice have an 
increased proportion (2 fold) of CD11bhi and CD11bhiCD43hi BM mNK cells compared 
to wt (Fig. 14A). Likewise, the proportion of CD11bhiCD43hi NK cells was increased in 
the liver and the spleen of Tcf-1-deficient mice (1.4 fold) (Fig. 15A and data not 
shown). NK cells can be divided into CD11b− CD27+ (immature), CD11b+CD27+ 
(mature1; M1), and CD11b+ CD27− (mature2; M2) subsets. The CD11b+CD27+ 
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subset is the most potent in acquiring effector functions whereas the M2 population 
mostly co-expresses KLRG1 that marks terminal maturation (Hayakawa and Smyth, 
2006). The M2 CD11b+ CD27− subset was strongly increased in the BM and the 
spleen of mice that lack Tcf-1 compared to wild type controls. Furthermore in the 
absence of Tcf-1 the bulk of mNK (50-60%) and splenic NK cells (75%) expressed 
KLRG1 compared to (5-8%) and (30%) of Tcf7+/+ NK cells (Fig. 14A). These data 
show that Tcf-1 deficient NK cells have a more mature phenotype. The expression of 
maturation markers in p33 Tg Tcf7-/- mice was comparable to wild type controls. 
However p45 Tg Tcf7-/- NK cells showed a very immature phenotype. Around 90% of 
the BM and 72% of splenic NK cells of p45 Tg Tcf7-/- mice were immature 
(CD11b−CD27+) compared to wt controls BM (54.8%) and spleen (35.5%), 
respectively. The mature M1 (CD11b+CD27+) NK cell fraction was strongly reduced 
in the BM and the spleen and the M2 (CD11b+CD27-) population was completely 
absent (Fig. 15A).  Furthermore, the NK cells of p45 Tg Tcf7-/- mice did not up-
regulate KLRG1. We conclude that enforced Tcf-1 p45 signaling prevents maturation 
whereas the absence of Tcf-1 accelerates maturation. 
 
2.7 Tcf-1 ensures the survival of BM and cytokine 
stimulated NK cells  
The analysis of NK cell surface markers in the absence of Tcf7 did not directly reveal 
why NK cell development was blocked at the mNK stage. The emergence of mNK 
cells coincides with rapid cycling of precursor cells (Kim et al., 2002). Thus the 
reasons for the reduced number of Tcf7-/- mNK cells could be a defect in cycling 
and/or survival. To examine cell proliferation we measured the DNA content of the 
cells using Hoechst staining. We found that Tcf-1-deficient BM mNK cells cycled 
(S/G2/M) at least as efficiently as control mNK cells (Fig. 17A). There was also no 
difference in the proportion of cycling NKp and iNK cells (Fig. 17A). Thus, even 
though Tcf-1-deficient BM NK cells cycle normally, their number fails to increase, 
suggesting that Tcf7-/- NK cells have a survival defect. 
Freshly isolated Tcf7 deficient BM mNK cells did not show increased Annexin V 
staining, which detects apoptotic cells (data not shown). However, following in vitro 
culture (4h) in the absence of exogenous growth factors a significantly increased 
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fraction of Tcf7-/- BM NK cells became Annexin V+ (44.0±1.4% n=5) as compared to 
wild type BM NK cells (27.5±1.9% n=5) (Fig. 17B). This observation was specific to 
BM NK cells since splenic NK cells did not show an increase in Annexin V+ cells 
following in vitro culture (4h) (not shown). Overall this suggests that Tcf-1 ensures 
the survival of BM NK cells.  
We further tested whether cytokine stimulation of splenic NK cells resulted in a 
corresponding impairment of expansion. In contrast to wild type NK cells, Tcf-1-
deficient NK cells failed to efficiently accumulate in number in response to either IL2 
or IL-15 stimulation (Fig. 17C). In response to IL-2 (or IL-15) Tcf7-/- NK cells showed 
normal cell cycle progression based on the combined analysis of BrdU incorporation 
and 7-AAD staining (Fig. 17E). In addition, as shown by the efficient dilution of CFSE, 
Tcf7-/- NK cells underwent as many cell divisions as wild type control NK cells (Fig. 
17F). At day 5 of cytokine stimulation, significantly more Tcf7-/- NK cells were Annexin 
V+ (19±2.0%) as compared to wild type (8±1.0%) (Fig. 17G). Corresponding data 
were obtained at day 3 and based on TUNEL assays (Tcf7+/+ 5.3±0.3% Tunnel+, 
Tcf7-/- 9.9±0.8% Tunnel +) (Fig.17F). When cell death (Annexin V) and cell division 
(CFSE) were simultaneously monitored we noted increased rates of cell death at 
each division both at day 3 and day 5 of cytokine stimulation, suggesting that at each 
division a certain fraction of proliferating cells undergoes apoptosis (not shown). 
Similar to BM NK cell development we found that the presence of the p33 Tg was 
sufficient to restore NK cell accumulation upon cytokine stimulation (Fig. 15D). Taken 
together, these data show that the poor accumulation of BM and cytokine stimulated 
splenic NK cells is caused by increased rates of cell death. Furthermore, we found 
that the suppressor activity of Tcf-1 prevent the apoptosis of cycling NK cells. 
Next we determined whether the death of cytokine activated NK cells idepended on 
Tcf-1 expression by NK cells or by the surrounding cells. Splenic Tcf7-/- (CD45.2) and 
Tcf7 +/+ (CD45.1) were mixed at a ratio of 1:1 and cultured for 5 days in vitro in the 
presence of IL-2. While Tcf-1 sufficient NK cells expanded normally, Tcf-1-deficient 
NK cells failed to efficiently accumulate (Fig. 18). Taken together these data show 
that Tcf-1 ensures the survival of proliferating BM mNK cells and cytokine stimulated 
peripheral NK cells in a cell autonomous fashion. 
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Figure 17. Tcf-1 is required for NK cell expansion.  
A. Hoechst (DNA) staining of the indicated NK cell populations in BM of Tcf7+/+ or Tcf7-/- mice. Hoechst 
positive cells are in S, G2, M phases of the cell cycle. Numbers show the mean percentage + SD of 
Hoechst positive cells in the different populations. These data are representative of 3 experiments. B. 
Annexin V (marker of apoptosis) staining of the indicated BM NK cell populations in Tcf7+/+ and Tcf7-/- 
mice cultured for 4 hours at 37°. Bar graphs depict the mean percentage (±SEM) of AnnexinV and 
7AAD positive cells (n=5). The statistical significance of differences was calculated using two-tailed t-
test and * shows statistical significance (p<0.05) compared to Tcf7+/+ mice. C. Nylon wool non-
adherent splenocytes from Tcf7+/+ or Tcf7-/- mice were stimulated with IL-2 or IL-15. Shown is one 
representative dot plot of at least 10 experiments for IL-2 stimulation. Bar graphs show the fold 
expansion of NK cells between day 0 and day 5 of stimulation + SEM. These data are representative 
of at least 10 experiments for IL-2 stimulation and for 3 experiments for IL-15 stimulation. The 
statistical significance of differences was calculated using two-tailed t-test and * shows statistical 
significance (p<0.05) compared to Tcf7+/+ (C2) or Tcf7+/- (C3) mice. D. Scatter plots depict the cell 
cycle distribution of gated NK cells at day 5 after IL-2 stimulation following treatment with 1 BrdU for 
45 min. Bivariate analysis of the DNA content (DAPI staining) and the incorporation of BrdU was 
performed. These data are representative of at least 3 experiments. E. Nylon wool non-adherent 
splenocytes were labeled with CFSE and stimulated with IL2 for 5 days. Numbers indicate the 
percentage of cells in the indicated gates. These data are representative of 9 experiments. F. Nylon 
wool non-adherent splenocytes were stimulated with IL2 for 5 days. The numbers indicate the 
percentage of cells in the indicated gates. These data are representative of at least 7 experiments. Bar 
Graphs: percentage of AnnexinV (left panel) or Tunnel (right panel) postive cells after 5 days of 
stimulation + SEM (n=4 for Annexin V and n=3 for Tunnel assays). 
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Figure 18. Cell intrinsic role of Tcf-1 for 
NK cell expansion. 
Bar graph depicts fold expansion of Tcf7 
+/+ (CD45.1+) and Tcf7 -/- (CD45.2+) NK 
cells were cultured separately (left) or as a 
1:1 mixture (right) for 5 days with IL-2. NK 
cell numbers were determined by gating 
on CD45.1+CD3-NK1.1+ for Tcf7 +/+ and on 
CD45.2+CD3-NK1.1+ for Tcf7 -/- cells. Bar 
graphs represent the mean number of 
indicated NK cells ± SEM of 3 
independent experiments. (**) depicts 
significant differences (p<0.01) on the 
student`s t-test. 
 
 
 
 
NK cell development and survival is critically dependent on cytokines. IL-15 
deficiency blocks NK cell development at the iNK stage (Vosshenrich et al., 2005). 
This cytokine is also required for NK cell homeostasis and may be necessary for NK 
cell expansion (Koka et al., 2003). The IL-15 receptor complex is composed of the IL-
15 receptor α (IL-15Rα), IL-2Rβ (CD122), and the IL-2 receptor common γ chains (IL-
2Rγc). Compared to their wild type counterparts, Tcf7-/- BM mNK and splenic NK cells 
expressed equivalent amounts of IL-2/15Rβ (Fig. 19A). IL-15R signaling mediates 
the survival of NK cells by promoting the expression of high levels of anti-apoptotic 
Bcl-2 and Bcl-XL. Moreover it has been shown that Bcl-2 family members regulate 
cytokine deprivation dependent apoptosis (Carson et al., 1997; Cooper et al., 2002; 
Ranson et al., 2003). Intracellular staining showed that the expression of Bcl-2 and 
Bcl-XL in freshly isolated or cytokine stimulated NK cells was unperturbed in the 
absence of Tcf-1 (Fig. 19). Taken together we conclude that the survival defect of 
Tcf-1 deficient NK cells is not caused by the reduced expression of the IL-15 receptor 
complex or by a decrease of the anti-apoptotic molecules Bcl-2 and Bcl-XL. 
 
 
 
 
 
Results 
	   41	  
Figure 19. The IL-15 receptor and the anti-
apoptotic molecules Bcl-2 and Bcl-X are normally 
expressed in the absence of Tcf-1. 
A. The graph depicts the MFI ±SEM of  IL-2/15Rβ 
expression in Tcf7-/-, p33 Tcf7-/-, p45 Tcf7-/- NK cells 
normalized to Tcf7+/+ controls that were set to 100%. 
(n=5). B. Expression of Bcl-2 and Bcl-XL in freshly 
isolated BM and splenic NK cells or IL-2 day 7 
stimulated NK cells. The open histogram represents 
the isotype controls. Numbers indicate the MFI of 
staining. These data are representative of 3 
experiments for freshly isolated cells and from a single 
experiment for stimulated NK cells. 
 
Contribution: 
Experiment for figure 19B was done by Grégoire 
Jeannet. 
  
 
 
 
2.8 Tcf-1-deficient BM NK cells over-express Granzymes  
To elucidate the mechanisms underlying apoptosis of NK cells, we established the 
global gene expression profiles of FACS-purified BM mNK cells (CD3-CD19-
CD122+NK1.1+DX5+) isolated from Tcf7+/+ and Tcf7-/- mice using Affymetrix arrays. 
Based on three independent data sets, 364 of 28'000 genes were differentially 
expressed (False discovery rate FDR (adjusted P value)< 10% and fold change (FC) 
> 1.5). A total of 205 genes were up-regulated and 159 genes were down regulated 
in Tcf7+/+ compared to Tcf7-/- BM NK mNK cells (Table 2).  
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Table 2. Gene expression profile of mNK cells derived either form Tcf7-/- or Tcf7+/+ mice. 
 
Cut-off UP DOWN 
 
 FDR < 5% 15 5  
 
FDR < 10% and FC > 1.5 205 159 
 
 
Based on three independent data sets, 20 FDR < 5% and 364 (False discovery rate FDR (adjusted P 
value)< 10% and fold change (FC) > 1.5) of 28'000 genes were differentially expressed). A total of 
205 genes were significantly up-regulated (green) and 159 genes were down regulated (red) in 
Tcf7+/+ compared to Tcf7-/- BM NK mNK cells 
 
 
 
As expected, Tcf7 transcripts were down regulated in NK cells, yet still detectable, 
which is in agreement with data obtained by qRT-PCR. However, in Tcf7-/- NK cells, 
Tcf-1 protein was not detected by Western blot (Held et al., 1999). Tcf7-/- NK cells 
showed higher mRNA levels of genes encoding Minichromosome maintenance 
factors (Mcm) (Mcm10, Mcm5, Mcm3), cyclin (cyclinF, cyclinA2, cdk14, cdk inhibitor 
Cdnk2c (p18, inhibits Cdk4, repressed by c-Myc)), E2Fs (E2F8, E2F2) in agreement 
with efficient cycling of Tcf7-/- mNK cells (Table 3, The Affimetrix microarray has been 
done by the Center for Integrative Genomics at the University of Lausanne). The 
transcript levels of the pro-apoptotic Bcl-2 family members Bim, Puma, Noxa or Bax 
in Tcf7-/- mNK cells were comparable to wt controls. Amongst the most up-regulated 
transcripts upon loss of Tcf7 was the gene encoding for GzmB (2.5-fold as 
determined by microarray, p<0.5 and 8.7-fold as determined by qRT-PCR analysis 
(Table 2 and Fig. 20D). Genes coding for other Granzyme family proteins, including 
Granzyme C (2.5-fold, p<0.05) and Granzyme K (2-fold, p<0.1) were also up-
regulated (Table 3). GzmB is a serine protease and the main component of exocytic 
granules used by cytotoxic T cells (CTL) and natural killer (NK) cells to destroy cells 
infected with intracellular pathogens or tumor cells (Russell and Ley, 2002). Recently 
several groups have reported GzmB-leakage-induced cell death in NK cells and 
CTLs where GzmB escapes into the cytoplasm, and thereby provokes apoptosis of 
the GzmB producing cell itself (Ida et al., 2003; Zhang et al., 2006). 
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Table 3. Gene expression profile of mNK cells derived either form Tcf7-/- or Tcf7+/+ mice. 
Gene 
accession nr. Gene Gene description 
adj. 
P.Val 
Tcf7-/- 
mean 
 
Tcf7+/+ 
mean 
Fold_ 
Change 
NM_009640  Angpt1  angiopoietin 1  0.020 5.1 7.0 -3.7 
NM_016970  Klrg1  killer cell lectin-like receptor subfamily G 0.030 9.7 7.6 4.1 
NM_013473  Anxa8  annexin A8  0.036 7.3 4.3 7.8 
NM_027127  Gpx8  glutathione peroxidase 8 (putative)  0.039 6.5 4.7 3.6 
NM_139198  Plac8  placenta-specific 8  0.039 9.3 8.1 2.3 
NM_009848  Entpd1  ectonucleoside triphosphate diphosphohydrolase 1  0.039 9.7 7.4 4.8 
NM_013542  GzmB granzyme B  0.039 11.4 10.1 2.5 
NM_009987  Cx3cr1  chemokine (C-X3-C) receptor 1  0.039 8.0 6.6 2.8 
NM_010371  GzmC  granzyme C  0.039 6.5 5.1 2.5 
NM_024477  Ttc28  tetratricopeptide repeat domain 28  0.039 7.0 8.2 -2.4 
NM_011311  S100a4  S100 calcium binding protein A4  0.039 11.2 10.2 2.0 
NM_030712  Cxcr6  chemokine (C-X-C motif) receptor 6  0.039 10.3 8.6 3.3 
NM_177660  Zbtb10  zinc finger and BTB domain containing 10  0.039 6.3 7.2 -1.9 
NM_009858  Cd8b1  CD8 antigen, beta chain 1  0.040 9.3 5.6 13.1 
NM_001163608  Plxdc1  plexin domain containing 1  0.044 5.4 4.5 1.8 
NM_011920  Abcg2  ATP-binding cassette, sub-family G  0.048 6.4 7.8 -2.5 
NM_008479  Lag3  lymphocyte-activation gene 3  0.050 6.6 5.6 2.1 
NM_010740  Cd93  CD93 antigen  0.050 6.7 5.7 1.9 
NM_011496  Aurkb  aurora kinase B  0.050 9.4 8.5 1.9 
NM_009331  Tcf7  transcription factor 7, T-cell specific  0.050 9.8 10.8 -2.0 
NM_027290  Mcm10  minichromosome maintenance deficient 10  0.059 7.6 6.9 1.7 
NM_026410  Cdca5  cell division cycle associated 5  0.059 8.4 7.5 1.8 
NM_001013368  E2f8  E2F transcription factor 8  0.059 8.4 7.6 1.8 
NM_007634  Ccnf  cyclin F  0.059 7.6 6.8 1.8 
NM_008196  GzmK granzyme K  0.059 9.3 8.3 2.0 
NM_177733  E2f2  E2F transcription factor 2  0.059 7.6 6.8 1.8 
NM_007671  Cdkn2c  
cyclin-dependent kinase inhibitor 2C (p18, 
inhibits CDK4)  0.059 9.0 8.2 
1.7 
NM_011074  Cdk14  cyclin-dependent kinase 14  0.059 7.2 6.5 
1.6 
NM_009828  Ccna2  cyclin A2  0.073 10.8 10.0 
1.7 
NM_008566  Mcm5 minichromosome maintenance deficient 5 0.073 8.8 8.2 
1.4 
NM_008563 Mcm3 minichromosome maintenance deficient 3  0.077 9.0 8.3 
1.5 
NM_011452 Serpinb9b 
serine (or cysteine) peptidase inhibitor, clade B, 
member 9b 0.497 7.9 7.7 1.2 
NM_009256 
Serpinb9 
(Spi-6) 
serine (or cysteine) peptidase inhibitor, clade B, 
member 9 0.808 9.5 9.4 1.1 
NM_009982 Ctsc cathepsin C 0.812 9.3 9.2 1.1 
NM_011453 Serpinb9c 
serine (or cysteine) peptidase inhibitor, clade B, 
member 9c 
0.831 
 3.1 3.2 -1.0 
NM_011456 Serpinb9e 
serine (or cysteine) peptidase inhibitor, clade B, 
member 9e 0.844 2.8 2.9 -1.1 
NM_183197 Serpinb9f 
serine (or cysteine) peptidase inhibitor, clade B, 
member 9f 0.901 3.3 3.2 1.0 
NM_011455 Serpinb9g 
serine (or cysteine) peptidase inhibitor, clade B, 
member 9g 0.963 2.8 2.8 1.0 
cDNA from FACS sorted BM mNK cells was analyzed on an Affymetrix microarray. Table 2 shows the 
gene accession number, symbol and description, the adjusted p-value, the mean expression of three 
independent data sets for Tcf7+/+ and Tcf7-/- and the fold change. Adjusted p-values have been 
computed for each comparison by the Benjamini-Hochberg method, controlling for false discovery rate 
(FDR). Expression values are measured using RMA algorithm from the BioConductor affy package. The 
expression values are on the log 2 scale and range from 0 to 16. First section: annotated genes with an 
FDR < 5%. Second section: genes with an FDR < 10% relevant for this thesis. Red: genes that are 
increased; green: genes that are decreased in Tcf7-/-. The last panel shows genes of interest that do not 
show a significant change in expression. Genes that are mentioned in this thesis are	  highlighted in bold. 
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Mature NK cells from naïve mice transcribe GzmB and Prf1 mRNA constitutively. 
However, such NK cells are minimally cytotoxic because of a block in Prf1 and GzmB 
mRNA translation that is only released by NK cell priming (Fehniger et al., 2007). In 
agreement with these data, splenic NK cells express little GzmB but they abundantly 
express GzmA as reported previously (Fehniger et al., 2007) (Fig. 20A). We also 
could not detect GzmB protein in NKP, iNK and mNK cells from wt mice. In contrast, 
Tcf7 deficient iNK and mNK cells abundantly expressed GzmB protein as determined 
by intracellular FACS staining (Fig. 20B). 
We decided to analyze the subcellular localization of GzmB in activated NK cells. We 
detected a granular GzmB localization in the cytoplasm of wild type NK cells, which 
co-localized with lysosome-associated membrane protein 1 (LAMP-1) (Fig. 21A). In 
sharp contrast, the activated Tcf7-/- NK cells showed a diffuse cytoplasmic distribution 
of GzmB and LAMP-1, which partly co-localized (Fig. 21A). Based on these 
observations we hypothesized that GzmB mediated, self-inflected damage may 
explain the increased cell death of proliferating Tcf-1 deficient NK cells.  
A major determinant of GzmB-leakage-induced cell death is an excess of cytosolic 
GzmB over the serine protease inhibitor 6 (Spi-6), its principal cytosolic inhibitor (Ida 
et al., 2003; Laforge et al., 2006; Phillips et al., 2004; Zhang et al., 2006). Spi-6 
prevents the processing of the N-terminal GzmB pro-peptide by the protease 
cathepsin C (or DPPI), which is required to unlock the proteolytic activity of GzmB 
(Caputo et al., 1993; Pham and Ley, 1999; Sun et al., 1997; Zhang et al., 2006). 
Based on the Affymetrix arrays Cathepsin C (Ctsc) and Spi-6 (serpinb9) or 
homologues (serpinb9b to serpinb9g) transcript levels were not different between 
wild type and Tcf7 deficient mNK cells (Table 3). In the absence of Tcf-1, Spi-6 levels 
in naïve splenic NK cells and in IL-2 activated NK cells were comparable to wild type 
controls (Fig. 21B). Thus in the absence of Tcf7, activated NK cells show increased 
levels of cytosolic GzmB, whereas Spi-6 levels remain unchanged. Spi-6 might 
therefore not be able to prevent GzmB induced self-inflected apoptosis. 
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Figure 20. GzmB is over-expressed in the absence of Tcf7. 
(A) Histograms show overlays of Granzyme A (upper panel) and Granzyme B (lower panel) expression 
in Tcf7+/+  (black line), Tcf7-/-  (filled grey for Granzmye A or filled red for Granzmye B) and GzB-/- or an 
isotype control (filled light grey) BM NKp, iNK and mNK (left) and splenic NK (right) cells like indicated. 
Following gating strategy was used for NKp (CD3-IL-2/15Rβ+NK1.1-DX5-), iNK (CD3-IL-
2/15Rβ+NK1.1+DX5-), mNK (CD3-IL-2/15Rβ+NK1.1+DX5+) and splenic NK (CD3-NK1.1+) cells 
respectively. (B) The bar graphs depict the MFI ±SEM of Granzyme B expression in Tcf7-/- and GzmB-/- 
NK cells in the spleen (mid panel) and in the BM (left panel) and at day 5 of IL-2 expansion (right panel), 
normalized to the Tcf7+/+ controls that were set to 100%. Shown are n=4 (IL-2 expansion) and n=12 
(splenic and mNK) independent experiments. (C) Western Blot showing the expression of Spi6 and 
GzmB in naïve splenic Tcf7+/+ and Tcf7-/- NK cells (left panel) and in NK cells at day 5 of IL-2 stimulation 
(right panel). JURKAT cell lysates were used as negative controls. Numbers indicate the relative density 
of Tcf7-/- adjusted to the Tubulin (53kD) loading control and to Tcf7+/+. The 50kD band represents Spi6 
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and the 22kD band shows GzmB. (D) Quantitative RT-PCR analysis of the GzmB gene expression 
Tcf7+/+ and Tcf7-/- mNK cells (left) and in IL-2 expanded NK cells (right) (n=3). Based on the two-tailed t-
test (*), (**) and (***) depict significant differences (p<0.05), (p<0.01) and (p<0.001) respectively, 
compared to Tcf7+/+ controls. 
  
Contribution: 
RT-PCRs shown in (Fig. 20C) were performed and analyzed by Beena-Jeevan-Raj (IL-2 activated NK 
cells) and by Georgi Angelov (mNK). 
 
It has previously been reported, using Spi-6 deficient cytotoxic T cells, that an excess 
of GzmB disrupts lytic granules (Zhang et al., 2006). To see whether the absence of 
Tcf-1 or an excess of GzmB influenced the granule stability in activated NK cells, we 
analyzed Tcf7xGzmB double deficient NK cells. The granular morphology of LAMP-
1+ exocytic lysosomes was restored in Tcf7-deficient NK cells lacking GzmB (Fig. 21). 
We estimated the average number of GzmB and LAMP-1 positive granules per NK 
cell cross-section. A cytokine activated NK cell showed on average 5 GzmB positive 
granules per cross-cell section that co-stained for LAMP-1 (Fig. 22A). In contrast, NK 
cells lacking Tcf-1 had only 0.9 clear GzmB positive granules per section but showed 
abundant diffuse GzmB staining that partly overlapped with similarly diffuse LAMP-1 
staining (Fig. 22A and B). In the combined absence of GzmB and Tcf-1, LAMP-1+ 
lysosomes were back to normal in terms of morphology and number (Fig. 22 A and 
B). Taken together, we find that GzmB is abundantly present in the cytoplasm of Tcf7 
deficient NK cells. Moreover, the integrity of LAMP-1+ granules is disrupted, and this 
was restored to normal by the absence of GzmB. This suggests that over-expression 
of GzmB due to the absence of Tcf7 leads to abundant GzmB in the cytoplasm, 
which may induce self-inflected NK cell death. 
Based on the findings in IL-2 activated NK cells, we explored the localization of 
GzmB in mNK cells. Translation of GzmB mRNA is prevented in wild type NK cells, 
and GzmB was only occasionally detected by confocal microscopy. The absence of 
Tcf-1 leads to enhanced GzmB mRNA expression and translation in mNK cells (Fig. 
20 and 21). Similar to activated NK cells, BM NK cells lacking Tcf-1 showed diffuse 
cytoplasmic/nuclear localization for GzmB. Only rare Lamp-1 positive granules could 
be detected and they did not co-stain for GzmB (Fig. 23A and B). This suggested that 
Tcf7-deficient mNK cells cannot compartmentalize GzmB in exocytic granules and 
that this leads to a cytpolsamic/nuclear accumulation of GzmB. Taken together, in 
the absence of Tcf-1 the GzmB gene is over-expressed. Furthermore, GzmB mRNA 
is translated into GzmB protein that accumulates in the cytoplasm and nucleus of 
mNK cells where it may induce apoptosis of the NK cell.
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Figure 21. GzmB leaks into the cytoplasm of IL-2 activated splenic Tcf7-/- NK cells. 
Purified Tcf7+/+Gzmb+/+, Tcf7+/+Gzmb-/-, Tcf7 -/-Gzmb+/+ and Tcf7-/-Gzmb-/- NK cells were expanded for 
5 days in IL-2 and FACS sorted for (CD3-NK1.1+). Subsequently NK cells were stained for 
Granzyme B (green), Lamp-1 (red) and DAPI (nuclear dye) (blue). Shown are representative NK cell 
cross sections out of at least three independent experiments with GzmB and Lamp-1 visualized by 
Laser-scanning Confocal Microscopy. Images are as follows: from left to right, Granzyme B, Lamp1, 
DAPI and their overlay. Isotype matched mAbs were used as negative controls for the Lamp1 
staining and GzmB-/- NK cells were used as a negative control for the GzmB staining.  
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Figure 22. GzmB leaks into the cytoplasm of IL-2 activated splenic Tcf7-/- NK cells. 
 (A) Bar graphs depict the number of granules per cell section for GzmB (left) and Lamp-1 (right) of 
(n=60) cells of the indicated genotypes. (B) A minimum of 80 cells per genotype (Tcf7 +/+Gzmb+/+, Tcf7 
+/+Gzmb-/-, Tcf7-/-Gzmb+/+ and Tcf7-/-Gzmb-/-) where analyzed in detail for the expression of GzmB 
(green) and LAMP-1 (red) and their co-localization (yellow), which was either defined as granular (left) 
or diffuse (right) as exemplified in (B). Bar graphs in (B) (left side) show the percentage of cells that 
either depicts GzmB or Lamp-1 granules and the percentage of cells in which Lamp-1 and GzmB co-
localize. Bar graphs in the right panel show the percentage of cells with diffuse GzmB or Lamp-1 
expression and the percentage of cells were GzmB and Lamp-1 co-localize. 
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Figure 23. Tcf7 deficient BM mNK cells express high levels of Granzyme B. 
(A) FACS sorted Tcf7+/+ and Tcf7-/- mNK cells stained for GzmB (green) and Lamp1 (red) and nucleus 
(blue). Shown are cross sections visualized by confocal microscopy. Images from left to right: GzmB, 
Lamp-1, nucleus and overlay. Shown are representative samples out of at least three independent 
experiments with n=6 mice, each. (B) Bar graphs depict the percentage of cells (n=70) that express 
GzmB, Lamp-1 or that show co-localized GzmB and Lamp-1 expression. 
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While GzmB protein is not expressed during BM development and in unprimed 
peripheral NK cells of wild type mice, we detected abundant GzmB protein in iNK, 
mNK and naïve peripheral NK cells in the absence of Tcf-1. The short Tcf-1 isoform 
(p33) was sufficient to suppress GzmB protein expression in Tcf7-/- iNK, mNK and 
peripheral NK cells. GzmB was also expressed at lower levels in cytokine-activated 
p33 Tg Tcf7-/- NK cells as compared to controls (Fig. 15E). These data show that p33 
Tcf-1 is sufficient to prevent GzmB expression, which correlates with a rescue of BM 
NK cell development.  
 
2.9 Absence of GzmB does not rescue development of Tcf-
1-deficient NK cells 
 
To verify the importance of GzmB repression for NK cell development, we used mice 
deficient in GzmB. In the mouse a large number of Granzyme genes (including (5′-
>3′) GzmB, C, F, G, L, N, D, and E) are present in the GzmB gene cluster. Beside 
GzmB, GzmC transcripts were also up regulated in Tcf-1 deficient mNK cells. 
GzmB−/−PGK-neo mice are deficient in GzmB and express reduced levels of GzmC 
and F due to the integration of the PGK-neo cassette (Pham et al., 1996; Revell et al., 
2005). We generated GzmB−/− Tcf7−/− mice. The mNK cell pool was similarly reduced 
(6.5 fold) in GzmB−/− Tcf7−/− mice as in Tcf7 deficient mice (Fig. 24A and B). In 
addition, peripheral NK cell numbers were also reduced (Fig. 25A and B). Thus, 
impaired mNK development in Tcf7 deficient mice was not rescued by the deletion of 
GzmB. Tcf-1 seems to control additional factors that are required for mNK cell 
survival.  
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Figure 24. The absence of GzmB is not sufficient to restore BM NK cell development in the 
absence of Tcf7. 
A. Dot plots of Tcf7 +/+Gzmb+/+, Tcf7 +/+Gzmb-/-, Tcf7 -/-Gzmb+/+ and Tcf7 -/-Gzmb-/- BM cells stained for 
the indicated markers. Numbers indicate the percentage of gated cells (for A left panel, numbers are 
the percentage of total cells whereas for the right panel of A numbers are the percentage of gated IL-
2/15Rβ +CD3- cells). Histograms show Ly49A, KLRG1 and GzmB expression in gated mNK cells. 
Numbers indicate the percentage of gated cells and the MFI of GzmB staining. (B) Bar graphs 
represent the mean number of cells in one hind leg ± SEM of n=4 mice. Based on the two-tailed t-test 
(*), (**) and (***) depict significant differences (p<0.05), (p<0.01) and (p<0.001) respectively, 
compared to Tcf7 +/+Gzmb+/+ controls. When nothing is marked, the values are not significantly 
different (p>0.05). 
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Figure 25. The absence of GzmB is not sufficient to restore splenic NK cell numbers in the 
absence of Tcf7. 
A. Dor plots of Tcf7 +/+Gzmb+/+, Tcf7 +/+Gzmb-/-, Tcf7 -/-Gzmb+/+ and Tcf7 -/-Gzmb-/- spleen cells stained 
for NK1.1 versus CD3. Histograms show Ly49A, KLRG1 and GzmB expression in gated NK (CD3-
NK1.1+) cells. Numbers indicate the percentage of gated cells and the MFI of GzmB staining. (B) Bar 
graphs represent the mean number of cells ± SEM of n=4 mice. Based on the two-tailed t-test (*), (**) 
and (***) depict significant differences (p<0.05), (p<0.01) and (p<0.001) respectively, compared to 
Tcf7 +/+Gzmb+/+ controls. When nothing is marked, the values are not significantly different (p>0.05). 
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2.10 Absence of GzmB restores cytokine driven expansion 
of Tcf-1-deficient NK cells 
In contrast to wild type NK cells, Tcf-1-deficient NK cells failed to efficiently 
accumulate in number in response to cytokine stimulation (Fig. 26). Intriguingly, in 
the absence of GzmB, the expansion of Tcf7 deficient NK cells was restored (Fig. 26). 
Compared to the wild type NK cells (9±2%), a significantly increased fraction of the 
Tcf7-/- NK cells was Annexin V+ (20±2%). The absence of GzmB in Tcf7 deficient 
mice led to a strong reduction of the apoptotic cell fraction (6±1% Annexin V+) (Fig. 
26B,E).  
 
 
Figure 26.  The expansion of Tcf7 deficient NK cells is restored by the absence of GzmB. 
Tcf7 +/+Gzmb+/+, Tcf7 +/+Gzmb-/-, Tcf7 -/-Gzmb+/+ and Tcf7 -/-Gzmb-/- splenocytes at day 5 of IL-2 
stimulation. (A) Numbers in dot plots, indicate the percentage of gated NK1.1+CD3- cells. (B) Scatter 
plots depict the expression of Annexin V versus 7AAD in the NK1.1+CD3- cells. Numbers indicate the 
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percentage of cells in the respective quadrant. Shown is one representative sample of at least three 
independent experiments. Histograms in (C) show GzmB and Ly49A expression in gated NK1.1+CD3- 
cells. (D and E) Bar graphs show fold expansion (D) and the percentage of Annexin V positive 
NK1.1+CD3- cells (E) ± SEM of n=4 (D) and n=3 (E) experiments. The statistical significance of 
differences was calculated using two-tailed t-test and (*), (**) and (***) show significant differences 
(p<0.05), (p<0.01) and (p<0.001) respectively, compared to Tcf7 +/+Gzmb+/+ mice. When nothing is 
marked, the values are not significantly different (p>0.05). 
 
 
These data show that the expansion of Tcf-1 deficient NK cells can be rescued by 
the absence of GzmB. This suggests that the absence of Tcf7 and as a consequence 
the up-regulation of GzmB induces apoptosis of the NK cells.  
 
2.11 NK cell function in the absence of Tcf-1 
We could not detect significant changes in the expression of activating NK cell 
receptors while certain inhibitory receptors were significantly reduced in the absence 
of Tcf-1. We next tested the ability of poly IC primed NK cells from Tcf7-/- mice to 
mount an effector response. As compared to wild type NK cells, stimulation with 
various tumor cells (RMA/S, RMA-H60, YAC-1) or monoclonal antibodies (mAbs) to 
activating NK cell receptors (NKp46, NK1.1 or NKG2D) induced a comparable 
production of the cytokine IFN-γ or of the chemokine MIP1α and a normal release of 
secretory granules (LAMP-1 release) by Tcf7-/- NK cells (Figs. 27 and 28). The only 
exception was a reduced IFNγ production in response to cross-linking with anti-NK1.1 
antibody (Fig. 28). 
We further tested the ability of Tcf7-/- NK cells to kill susceptible target cells in vitro. 
As expected, the Poly IC primed splenocytes from normal mice efficiently killed 
RMA/S tumor target cells while syngeneic MHC-I+ RMA cells were not killed (Figs. 
28A, B and C). In contrast, Tcf7-/- mice had a 5-10 fold reduced ability to kill RMA/S 
cells (Fig. 29B). Tcf7-/- mice also showed significantly reduced antibody-dependent 
cell-mediated cytotoxicity (ADCC) towards Thy1 coated RMA cells. In addition, they 
showed impaired killing of RMA-m157 (Ly49H) and of YAC-1 (in part NKG2D) target 
cells (Fig. 29C). As an exception, Tcf7-/- NK cells killed RMA-H60 cells as efficiently 
as wild type controls, suggesting that high levels of NK cell activation through 
NKG2D can restore normal target cell killing by Tcf7-/- NK cells (Fig. 29C). 
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Figure 27. Tcf7 deficient NK cells mount produce cytokine and chemokine upon target cell 
recognition. 
(A) Dot plots show splenocytes of poly IC primed mice gated for CD3- versus NK1.1+. (B) Density 
plots show representative examples of LAMP-1 release versus INFγ (left panel) or versus MIP1a 
(right panel) by poly IC primed Tcf7+/+ and Tcf7-/- NK cells in response to the MHC-I expressing RMA 
cells (negative control) or of different tumor target cell lines that are either MHC-I low (RMAS) 
(missing-self) or over-express activating NKG2D ligands (RMA-H60, YAC-1). As a positive control 
cells were stimulated with Phorbol 12-myristate 13-acetate (PMA) and Ionomycin (I) indicated as 
(P/I). Numbers represent the percentage of positive cells within the respective gates. Shown is one 
representative experiment out of at least 4.  
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Figure 28. Tcf7 deficient NK cells mount a normal cytokine and chemokine response upon 
target cell recognition or mAb stimulation. 
A. Total spleen cells from Poly IC primed Tcf7 +/+ and Tcf7 -/- mice were exposed to MHC-I expressing 
RMA cells (negative control) or to different tumor target cell lines that are either MHC-I low (RMAS) 
(missing-self) or over-express activating NKG2D ligands (RMA-H60, YAC-1) (induced-self) 
respectively. Further some NK cells were stimulated via activating receptors with immobilized mAb 
(NK1.1, NKp46, NKG2D). As a positive control PMA and Ionomycin (P/I) was added. After 5 hours 
NK cells (CD3−CD19−DX5+) were analyzed for intracellular (ic) IFNγ (A.) or MIP-1a production (C.). 
The capacity of NK cells to de-granulate upon target cell recognition was measured by LAMP-1 
expression (B.). Bar graphs depict the mean percentage (±SD) of (A.) IFNγ-positive (C.) MIP1α 
positive or (C) LAMP-1 positive cells among gated NK cells (n=10). Statistical significance of 
differences between Tcf7 +/+ controls and Tcf7 -/- NK cells were determined with the two-tailed 
Student's t test: ∗ p < 0.05; When nothing is marked, the values are not significantly different 
(p>0.05).  
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Figure 29. NK cells from Tcf7 deficient mice show reduced target cell killing. 
(A) The lytic activity of Poly IC-activated NK cells, from Tcf7 +/+ and Tcf7 -/- mice was tested against 
different tumor cell lines. Target cells were labeled with CFSE and cell death within the CFSE positive 
population was measured by 7AAD incorporation. B. Poly IC primed Tcf7 +/+ and Tcf7 -/- splenocytes 
were exposed to RMA (H-2b) or with RMA/S (MHC-Ilow) tumor cells at different effector:target ratios. 
Five hours later the percentage of dead target cells was determined by FACS Graph in B shows the 
mean percentage of specific lysis (spontanious death is subtracted) of at least 10 independent 
experiments. C. Bar graphs represent the percentage of specific lysis using the indicated target cells 
(RMA (H-2b), RMAS MHC-Ilow, RMA-H60 or RMA-m157). Antibody dependent cellular cytotoxicity 
(ADCC) was tested using anti-Thy1 (CD90.2) coated RMA cells. Bar graphs show the mean % of 
specific lysis  ± SD of n=6 independent experiments. Based on the two-tailed t-test (*), (**) and (***) 
depict significant differences (p<0.05), (p<0.01) and (p<0.001) respectively, compared to Tcf7+/+ 
controls. When nothing is marked, the values are not significantly different (p>0.05). 
 
 
Finally we tested the functionality of NK cells in Tcf7-/- mice using in vivo lysis of β2m-
deficient (MHC-Ilow) splenocytes. In contrast to wild type and Tcf7+/- mice, which 
readily rejected β2m-deficient splenocytes, Tcf7-/- mice completely failed to reject 
β2m-deficient splenocytes (Fig. 30A). We verified whether deficient rejection was due 
to impaired NK cell priming. In response to Poly IC, the Tcf7-/- NK cells efficiently up-
regulated CD69 (Fig. 30B) (Lucas et al., 2007), and expressed intracellular GzmB 
and Perforin (Fig. 30C) (Fehniger et al., 2007), thus indicating that Tcf7-/- NK cells 
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were efficiently primed. Collectively these data suggest that Tcf7-/- NK cells can 
efficiently respond to cellular targets by releasing cytokines and chemokines. Cell-
mediated lysis in vitro and particularly in vivo is impaired, despite proper priming and 
the expression of Perforin and Granzmye B protein.  
 
 
Figure 30. Tcf7 deficient mice fail to reject β2m-deficient cells in vivo.  
A. The functionality of NK cells in Tcf7-/-	  mice was tested using in vivo lysis of β2m-deficient (MHC-
Ilow) splenocytes. Poly IC primed wilde type and deficient mice were injected with a 1:1 mixture of β2m 
(CFSE low) and H-2b (CFSE high) splenocytes. Bar graphs show the percentage of relative rejection 
calculated as follows {100-[(% final β2m cells / % final H-2b cells)/(% initial of β2m cells/ % initial H-2b 
cells) x 100])}. The statistical significance of differences between groups of data was calculated using 
a one-way analysis of variance (one-way ANOVA) along with the Dunnet's post-test to adjust for 
multiple comparisons, using a 95% confidence interval. (***) depicts statistical significance (p<0.001) 
compared to Tcf7+/+ (n=5). B and C. Histograms show the expression of the activation marker CD69 
(indicates that NK cell are primed) or Perforin (C upper panel) or GzmB (C lower panel) in gated NK 
(CD3-CD19- NK1.1+) in Poly IC primed (black line) or unprimed (filled grey) Tcf7+/+ and Tcf7-/- mice. 
Shown is one representative example out of at least 3 independent experiments. 
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To test the ability of Tcf-1 deficient NK cells to control tumor growth in vivo, we  
established β2m-deficient (MHC-Ilow) B-ALL (B cell acute lymphoid leukemia) cell 
lines, which are rejected in a NK cell dependent fashion. To this end, β2m-/- BM cells 
were infected with pMSCV–BCR-ABL1 (p185) -IRES-eGFP retrovirus.  Following 7 
days in culture, 90% of the BM cells were transformed (GFP+) and positive for 
markers characteristic for B-ALL (B220+, CD43+, BP1+). Tail vein injections of 2 x 106 
infected bone-marrow cells lead to the rapid onset of B-ALL disease in NK cell 
depleted wild type hosts whereas control mice were resistant to the disease (Fig. 
31B).  
 
Figure 31. Tcf-1 deficient NK cells are not able to control tumor growth in vivo. 
β2m-/- BM cells were infected with pMSCV–bcr/abl p185-IRES-eGFP retrovirus. Subsequently 2 x 106 
infected bone marrow cells (90% (B220+, CD43+, BP1+ GFP+)) were injected into the tail vein of 
non-irradiated Tcf7+/+ and Tcf7-/- mice that had been depleted of NK cells (with anti NK1.1) or not. (A) 
Histograms show GFP expression in blood B cells (B220+) of Tcf7+/+, Tcf7+/+ + anti NK1.1, Tcf7-/- and 
Tcf7-/- + anti NK1.1 mice at day 10 after tumor cell injection. Numbers indicate the percentage of 
gated cells ±SD of two independent experiments. (n=5 for NK cell sufficient and 3 for the NK cell 
deficient controls). (B) Graph shows the survival curves of the indicated types of mice that have been 
injected with β2m-/- BALL cells.  
Contribution: 
Camille Grandclement established the B-ALL model and provided B_ALL cells for the injections.  	  
 
These data show that growth of β2m -/- B-ALL is controlled by NK cells in vivo. We 
next addressed whether Tcf-1 deficient mice controlled tumor growth in vivo. At day 
10 after injection Tcf7+/+ mice had no GFP+ B220+ B-ALL cells (0.33±0.09%) in the 
blood whereas GFP+ B220+ B-ALL cells (42.37±6.11%) were very abundant in mice 
that lack Tcf7 (Fig. 31A). There was no significant difference when Tcf7-/- mice were 
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NK cell depleted (56.53±9.62%), indicating that NK cells in mutant mice are entirely 
unable to control B-ALL (Fig. 31A). In contrast to wild type mice, which remained 
healthy, all Tcf7-/- mice had to be sacrificed around day 17-22 because they showed 
severe disease symptoms (Fig. 31B). Symptoms included weight loss, weakness, 
hunched posture and/or paralysis of the posterior legs, due to secondary tumors in 
the spinal cord. Further analysis of sacrificed animals revealed a moderate 
splenomegaly, enlarged LN and a dramatic expansion of cells with a pre-B cell 
phenotype, B220+ CD43- BP-1+ (not shown). Taken together these data suggest that 
the NK cells in Tcf7 deficient mice are not able to control tumor growth in vivo.  
 
2.12 Granzyme B mediates target cell induced death of 
Tcf7-/- NK cells  
Tcf-1-deficient NK cells are unable to efficiently lyse tumor target cells in vitro and in 
vivo (Figs. 29 and 31). Based on the over-expression of GzmB, we hypothesized that 
NK cells undergo self- inflected damage upon activation by target cells. Therefore we 
assessed NK cell death in response to target cells. Splenocytes from Poly IC primed 
Tcf7+/+ and Tcf7-/- mice were co-cultured with RMA/S (MHC-I-) tumor target cells. As 
compared to wild type NK cells (8.4±1.9% 7AAD+ n=5) a significantly increased 
fraction of Tcf7-/- NK cells underwent cell death (21.1±1.8% 7AAD+ n=5) (Fig. 32) in 
response to susceptible RMA/S target cells. In the absence of target cells or the 
presence of NK cell resistant RMA cells we did not detect an increased fraction of 
7AAD+ Tcf-1 deficient NK cells (Figs. 32A and B). Thus Tcf7 deficient NK cells 
undergo increased cell death only upon target cell recognition. 
Next we determined whether the increased NK cell death is mediated by GzmB. The 
addition of a GzmB inhibitor (z-AAD-CMK) prevented the increased cell death of Tcf-
1 deficient NK cells in response to RMA/S targets whereas a control inhibitor (z-FA-
CMK) did not rescue NK cells (Figs. 31A and B).  Furthermore, blockade of cathepsin 
C (dipeptidyl peptidase I, DPP-I) whose activity is required for GzmB activation 
(Meade et al., 2006) also reduced the death of Tcf7-/- NK cells (Figs. 32 A and B). On 
the other hand z-VAD, which blocks the activity of several major caspases, did not 
prevent the death of Tcf-1 deficient NK cells (Figs. 32A and B). Thus Poly IC 
activated Tcf-1 deficient NK cells undergo accelerated cell death in response to 
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susceptible target cells and this can be prevented by the inhibition of GzmB or 
cathepsin C. 
 
Figure 32. Accelerated cell death of Tcf7 deficient NK cells upon activation by target cells 
depends on GzmB. 
 A. Histograms depict splenic NK cells (CD3-CD19-NK1.1+) from Poly IC primed Tcf7 +/+ and Tcf7 -/- 
mice that have been exposed to susceptible RMA/S or resistant RMA tumor cells. Numbers show the 
percentage of dead (7AAD+) NK cells. The assays was performed n the presence of the GzmB 
inhibitor (z-AAD-CMK) (100uM), its negative control peptide (z-FA-CMK (100uM)), the caspase 
inhibitor (z-VAD (50uM) or the cathepsin C inhibitor (DPPI (15-25 uM)). These data are a 
representative of at least 3 independent experiments n=3-9. (B) Bar graphs depict the mean 
percentage (±SEM) of 7AAD-positive Tcf7+/+ and Tcf7-/- NK cells. (C) Histogram show the mean 
percentage (±SEM) of dead (7AAD+) Tcf7 +/+Gzmb+/+, Tcf7 +/+Gzmb-/-, Tcf7 -/-Gzmb+/+ and Tcf7 -/-
Gzmb-/- NK cells that have been primed exposed to susceptible RMA/S or resistant RMA tumor cells 
(*), (**) and (***) depict significant differences (p<0.05), (p<0.01) and (p<0.001), respectively based 
on the student`s t-test. When nothing is marked, the values are not significantly different (p>0.05). 	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Finally we used Tcf7xGzmB double ko mice to verify whether NK cells undergo cell 
death in response to susceptible tumor target cells. Indeed the absence of GzmB 
rescued Tcf7 deficient NK cells from target induced cell death (Fig. 32C). We 
conclude that Tcf-1 is essential for the killing of tumor target cells by protecting NK 
cells from GzmB mediated self-inflected injury. 
 
Data contribution: All experiments and analyses have been performed by Jasmine 
Gehrig if not stated otherwise. 
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3 Discussion 
3.1 An essential role of Tcf-1 for NK cell development 
In the first part of this thesis we defined the T cell factor-1 (Tcf-1) dependent stages 
of NK cell development. We found that Tcf-1 is highly expressed at the immature NK 
(iNK) and mature NK (mNK) cell stages. Next, we addressed the question of whether 
NK cell development is associated with canonical Wingless/Integration-1 (Wnt) 
signaling. Tcf-1 binds to DNA but lacks intrinsic transcriptional activity. Target gene 
activation in response to Wnt signals depends on the co-activators -catenin and γ-
catenin, which bind to the N-terminus of Tcf-1. In contrast, target gene repression is 
mediated via the association with the Groucho (Gro) co-repressors that bind to a 
more central domain of Tcf-1 (Grigoryan et al., 2008; Jeannet et al., 2008a). We 
found that Wnt signaling (assessed by conductin reporter activity) is strongly induced 
during the NKp to iNK transition and is maintained in a subset of mNK cells. 
Importantly, this signal was entirely dependent on Tcf-1 in both splenic, as well as 
BM mNK cells. Thus the up-regulation of Tcf-1 at the iNK stage correlates with Tcf-1 
mediated Wnt signaling. 
In order to define if Wnt signaling drives NK cell development, we used a genetic 
complementation approach. Surprisingly we found that the short Tcf-1 isoform (p33), 
which only contains the DNA- and Gro-binding domains (Oosterwegel et al., 1991a; 
Van de Wetering et al., 1996), is sufficient to restore NK cell development in Tcf-1-
deficient mice (Fig. 14 and 15). NK cell development is also restored by a p45 
transgene (Tg), which includes the N-terminal β-catenin-bining domain of Tcf-1. In 
agreement with these findings, we found that β- and γ-catenin are dispensable for NK 
cell development (Fig. 13). Thus, NK cell development is dependent on binding of 
Gro co-repressors to Tcf-1 at the DNA, whereas canonical Wnt signaling mediated by 
the N-terminal domain of Tcf-1 is dispensable.  
Our laboratory has previously shown that T cell development depends on the N-
terminus of Tcf-1, i.e. the p45 Tcf-1 isoform. Importantly, in this thesis we show that 
the regulation of the NK cell development differs from T cell development. NK cell 
development is restored by p33 and does not rely on signals mediated through the N-
terminal domain of Tcf-1. Thus, we found an important molecular difference between 
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T and NK cell development. The two subsets depend on different Tcf-1 domains that 
mediate different functions. T cell development depends on target cell activation via 
the N terminal domain, whereas the repressor function of Tcf-1 is crucial for NK cell 
development. Here we demonstrate for the first time that the repressor function of 
Tcf-1 specifically drives an immunological process. 
Recently it has been shown that Tcf-1 is essential for the development and/or 
differentiation of innate lymphocyte subsets including group 2 innate lymphoid cells 
(ILC2) and NKp46+ ILC3 cells (Mielke et al., 2013; Yang et al., 2013). However, the 
precise role of Tcf-1 in this process still remains to be elucidated. As NK cells and the 
ILC lineages are closely related, it would be interesting to test if the repressor p33 
isoform of Tcf-1 is sufficient to restore ILC development as well. 
Even though NK cell development is restored by both, Tcf-1 p33 and p45, there are 
differences between the two: Enforced p45 expression in Tcf7 deficient mice reduces 
the maturation of developing NK cells. Such mNK cells do not up-regulate KLRG-1, 
CD11b and CD43, but maintain high levels of CD27, a hallmark of immature NK cells. 
Conversely, in the absence of Tcf7, NK cells have a more mature phenotype. These 
NK cells express KLRG-1, CD11b and CD43, while CD27 is reduced compared to 
wild type. The maturation status of Tcf7 deficient NK cells that express the p33 Tg 
was comparable to that of wild type (Fig. 14 and 15). Peripheral NK cells can be 
divided into CD11b− CD27+ (immature), CD11b+CD27+ (mature1; M1), and 
CD11b+CD27− (mature2; M2) cells, with the immature CD11b−CD27+ NK cell 
population having a very low cytotoxic potential (Huntington et al., 2007). In p45 Tg 
Tcf7 deficient mice, almost all NK cells show an immature CD11b−CD27+ phenotype. 
We propose a model in which distinct stages of NK cell maturation depend on 
different functions of Tcf-1. While enforced canonical Wnt signaling (p45 function) 
keeps NK cells at a very immature stage, the p33 isoform allows normal maturation, 
whereas total loss of Tcf-1 results in accelated maturation (Fig. 33). 
In contrast to several other transcription factors that are required for NK cell 
development and have been shown to promote NK cell maturation, e.g. the E4-
binding protein 4 (E4bp4), the interferon regulatory factor (IRF), GATA-3 and T-bet 
(Gascoyne et al., 2009; Gordon et al., 2012; Lohoff et al., 2000; Male et al., 2011; 
Samson et al., 2003; Taki et al., 2005), Tcf-1 dampens NK cell differentiation and 
thus plays a unique role for NK cell maturation (Fig. 33). Those findings suggest that 
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NK cell maturation is governed by the interplay of transcription factors that drive or 
inhibit NK cell differentiation, respectively. 
 
	  
 
Figure 33. Enforced canonical Wnt signaling (p45 function) prevents maturation of NK cells. 
NK cells can be divided into CD11b− CD27+ (immature), CD11b+CD27+ (mature1; M1), and CD11b+ 
CD27− (mature2; M2) subsets. The CD11b+CD27+ subset is the most potent in acquiring effector 
functions whereas the M2 population mostly co-expresses KLRG1 that marks terminal maturation. In 
Tcf7+/+, and Tcf7-/-p33 mice the M2 subset represents the smallest population. In the absence of Tcf-1 
maturation is accelerated and most NK cells show a terminal mature M2 CD11b+ CD27− KLRG+  
phenotype. Conversely, in p45 Tg Tcf7 deficient mice, almost all NK cells show an immature 
CD11b−CD27+ phenotype, suggesting that enforced canonical Wnt signaling (p45 function) prevents 
maturation. The yellow bar represents the relative number of cells in the different maturation stages 
for the indicated genotype. 
 
3.2 Basis for impaired NK cell development 
The emergence of mNK cells coincides with the rapid cycling of BM NK cells (Kim et 
al., 2002). We found that Tcf-1 deficient NK cells in the bone marrow cycle as 
efficiently as in control mNK cells, but undergo accelerated apoptosis (Fig. 17).To 
identify candidates that could mediate apoptosis of Tcf-1 deficient mNK cells, we 
established the global gene expression profiles of BM mNK cells isolated from Tcf7+/+ 
and Tcf7-/- mice using Affymetrix arrays. Amongst the most up regulated transcripts in 
the absence of Tcf-1, was the gene encoding Granzyme B (GzmB) (Fig. 34). Genes 
coding for other Granzyme family proteins, including GzmC and GzmK were also up-
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regulated (Table 1 and 2). The Affimetrix analysis did not show any differences for 
Perforin transcript levels. 
 
 
Figure 34. The  repressor function of the short p33 Tcf-1 isoform is sufficient to control GzmB 
expression and to ensure survival of proliferating NK cells. 
Shown is the sequential maturation of NK cells in the BM of Tcf7+/+ and Tcf7-/-p33, Tcf7-/- or Tcf7-/-p45 
mice. The model proposes that the the suppressor activity of Tcf-1 (p33) is vital to ensure the survival 
of expanding mNK cells and for the suppression of GzmB (top panel). In the absence of Tcf7 NK cell 
maturation is accelerated, GzmB is up-regulated and translated and the expanding mNK cells 
undergo increased cell death (middle panel). Enfored signalling mediated by the N-terminal domain of 
Tcf-1 (present in p45) prevents maturation (bottom panel). 
 
GzmB is a serine protease that together with Perforin is a main component of 
exocytic granules in cytotoxic T cells (CTL) and NK cells. Such granules are a 
hallmark of cell types that are able to kill cells infected with intracellular pathogens or 
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tumor cells (Russell and Ley, 2002). Upon target cell recognition, lytic granules are 
polarized towards the immunological synapse where they fuse with the plasma 
membrane. Their content is relased into the synaptic cleft between effector and 
target cell. Subsequently GzmB enters the target cells through pores in the plasma 
membrane formed by Perforin (Long et al., 2013; Voskoboinik et al., 2006; Wang et 
al., 1996). Once present in a target cell, GzmB can activate multiple caspases, 
including caspases 1, 2, 3, 6, 7, 9, and 10 (Lieberman, 2003), but apoptosis induced 
through the activation of caspase 3 seems to be the main pathway in GzmB 
mediated cytotoxicity (Ewen et al., 2012). GzmB can directly activate some caspase 
substrates as well, including PARP and NuMA (Beresford et al., 1999). Additionally, 
GzmB has been shown to promote permeability of the mitochondrial outer membrane 
and to activate t-BID as well as to cleave ICAD independently of caspases (Barry et 
al., 2000; Thomas et al., 2001).  
In addition to killing other cells, GzmB-leakage into the cytoplasm can induce cell 
death in NK cells and CTLs (Ashton-Rickardt, 2013). It has previously been shown 
that primed NK cells undergo increased cell death when they are stimulated with 
antibodies against certain activating receptors (Ida and Anderson, 1998; Ida et al., 
1997). CD2-induced activation of IL-2 primed NK cells leads to GzmB mediated self-
inflected damage (Ida et al., 2003). In addition, T cell receptor-induced cell death 
(TCR-ICD) of Th2 cells is mediated by GzmB-induced self-inflicted damage, 
independently of caspase activation (Devadas et al., 2006). Moreover, it has been 
shown that iNKT cells undergo increased GzmB mediated self-inflicted damage in 
response to Ag stimulation (Ansari et al., 2010). Finally c-Myc and N-Myc deficient 
HSCs over-express GzmB and undergo increased cell death (Laurenti et al., 2008).  
Mature and BM NK cells in naïve mice express GzmB and Perforin mRNA 
constitutively. Importantly, resting or BM NK cells are minimally cytotoxic, because 
Perforin and GzmB mRNAs are not translated. In agreement with these data we 
could not detect any GzmB and Perforin protein in developing NK cells from wild type 
mice. The mechanisms that prevent the translation are currently not well understood. 
This translational block is overcome upon NK cell priming by cytokines like IL-15, IL-2 
and IL-18 that are produced early in an immune response by infected or activated 
dendritic cells (DCs) and macrophages (Fehniger et al., 2007; Stetson et al., 2003; 
Walzer et al., 2005). In contrast, in the absence of Tcf7, GzmB is detected in BM 
(from the iNK stage onwards) and spleen NK cells even in the absence of priming, 
Discussion 
	  68	  
suggesting that Tcf-1 is involved in the regulatory mechanism responsive to NK cell 
priming. The presence of the short p33 domain of Tcf-1 engaging Gro co-repressors 
was sufficient to regain wild type like GzmB control (Fig. 34). 
Upon cytokine stimulation NK cells increase in size and develop a high number of 
GzmB containing cytotoxic granules in their cytoplasm. Activated NK cells that lack 
Tcf-1 express much higher levels of GzmB mRNA and slightly more GzmB protein 
than their wild type counterparts. We show that cytokine stimulation of Tcf-1 deficient 
splenic NK cells results in the impairment of expansion. Similar to bone marrow mNK 
cells, cytokine stimulated NK cells are cycling normally but undergo accelerated cell 
death (Fig. 17). The presence of the short p33 domain of Tcf-1 was sufficient to 
restore NK cell expansion in the absence of Tcf7. Furthermore, enforced p33 
expression significantly decreased GzmB levels compared to wild type controls. 
GzmB is produced as a pro-peptide and needs to be cleaved by the protease 
cathepsin C (or DPPI) to gain proteolytic activity. In cytokine activated and primed 
wild-type NK cells, GzmB is stored in exocytic Lamp-1 positive granules present in 
the cytoplasm. Granzymes are packaged into the cytotoxic granules via the mannose 
6-phosphate receptor (MPR) pathway (Lopez et al., 2012). In the granules, 
Granzymes and Perforin are kept inactive by low pH and calcium concentrations. In 
fact, activated NK cells and CD8 T cells contain small amounts of GzmB in their 
cytoplasm (Ashton-Rickardt, 2013). This suggests that some GzmB might leak from 
the granules or that some newly synthesized GzmB does not properly traffick to the 
granules but may be secreted via the constitutive secretory pathway as described 
previously (Isaaz et al., 1995). However, the serine protease inhibitor 6 (Spi-6) that is 
present in the cytoplasm of activated cytotoxic cells captures free GzmB and 
prevents its processing and activation as a protective mechanism (Fig. 35). Free 
GzmB in the cytoplasm of Spi-6 deficient cytotoxic T cells disrupts lytic granules, this 
results in GzmB-mediated apoptosis (Ansari et al., 2010; Zhang et al., 2006). 
Therefore, the major determinant of GzmB-leakage-induced cell death seems to be 
an excess of free active GzmB over its principal cytoplasmic inhibitor Spi-6 (Ida et al., 
2003; Laforge et al., 2006; Phillips et al., 2004; Zhang et al., 2006). Here, we show 
that Spi-6 was expressed at normal levels in naïve and activated Tcf-1 deficient NK 
cells, whereas GzmB levels were significantly elevated (Fig. 20). 
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Figure 35. Tcf-1 deficient NK cells undergo self-inflected damage upon target cell recognition. 
Following priming by cytokines NK cells translate pre-formed mRNAs for GzmB, INFγ and Perforin. 
Subsequently in a wild type situation (Tcf7+/+) target cell recognition and activation triggers polarization 
of lytic granules filled with GzmB and Perforin towards the immunological synapse, where they fuse 
with the plasma membrane and release their contents into the synaptic cleft between effector and 
target cell (left panel). GzmB enters the target cells with the help of Perforin, and rapidly induces 
apoptosis via both, caspase-dependent and caspase-independent mechanisms. GzmB is expressed 
as an inactive precursor protein that carries an N-terminal signal peptide that directs packaging of the 
protein into secretory granules. Removal of the dipeptide Gly-Glu at the N-terminus of pro-GzmB by 
the cysteine protease cathepsin C generates the enzymatically active form of GzmB. The principal 
cytoplasmic inhibitor of GzmB is the serine protease inhibitor 6 (Spi-6). Spi-6 prevents the processing 
of an N-terminal pro-peptide by the protease cathepsin. NK cells that lack Tcf7 (right panel) over-
express GzmB while Spi-6 levels remain unchanged. That leads to free pro-GzmB in the cytoplasm 
that can be cleaved by Cathepsin C. Active GzmB induces apoptosis and death of the host cell (right 
panel). Therefore NK cells show impaired in target cell killing in the absence of Tcf7. 
 
In contrast to the discrete Lamp1 positive granules observed in cytokine activated 
wild type NK cells, cytokine activated Tcf-1 deficient NK cells show a diffuse 
distribution of GzmB and Lamp-1 in the cytoplasm (Fig. 21 and 22). To exclude that 
Tcf-1 deficiency plays a direct role for granule stability in activated NK cells, we 
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analyzed Tcf7xGzmB double deficient NK cells and found granular LAMP-1 staining  
to be restored. Therefore, we conclude that it is the excess of GzmB that destroys 
the integrity of lytic granules and not the absence of Tcf-1 per se or different 
downstream targets that lead to an accumulation of free GzmB in the cytoplasm. 
 
To determine whether GzmB mediates accelerated NK cell death, we generated 
mice deficient for both, GzmB and Tcf7. GzmB deficiency restored the expansion of 
peripheral NK cells lacking Tcf7. Thus the observed self-inflicted cell death is indeed 
caused by the elevated GzmB levels (Fig. 35). However, the absence of GzmB was 
not sufficient to restore NK cell development in Tcf7-deficient mice. Besides GzmB, 
GzmC was also up regulated in Tcf7 deficient mNK cells. GzmB deficient mice also 
express reduced levels of GzmC and F, which are just downstream in the GzmB 
gene cluster (Pham et al., 1996; Revell et al., 2005). It is thus not likely that GzmC or 
F play a significant role at this stage of NK cell development. 
Based on these findings we conclude that Tcf-1 regulates an additional factor that is 
required for the survival of mNK cells. A third Granzyme that is increased in the 
absence of Tcf7 is GzmK, which is located in a distinct cluster together with GzmA. 
GzmK can also induce rapid caspase-independent cell death in target cells (Zhong et 
al., 2012). So far it is not known whether GzmK is constitutively expressed in NK 
cells like GzmA, or whether it is translated and/or transcribed upon priming like 
GzmB. A single study with human NK cells showed that GzmK is mostly expressed in 
the CD56high NK cell population. Conversely, GzmB is primarily expressed in the 
CD56low NK cell subset, while GzmA is constitutively expressed in both subsets. 
These findings suggest that similar to GzmB, GzmK expression is not constitutive, 
but depends on specific triggers (Bratke et al., 2005). Although it is not known 
whether GzmK can mediate self-inflected damage, it is tempting to speculate it might 
act in a similar manner as GzmB when present in the cytoplasm. Therefore, further 
experiments are needed to test if GzmK mediates accelerated cell death in Tcf-1 
deficient mNK cells lacking GzmB. Employing a GzmK specific inhibitor or Tcf7, 
GzmB and GzmK deficient mice would be a way to test if GzmK mediates self-
inflected damage of Tcf7 and GzmB deficient mNK cells. 
 
Taken together, the data suggest that under steady state conditions GzmB 
expression is suppressed by Tcf-1. Two reasons could account for the enhanced 
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presence of GzmB protein in the absence of Tcf-1. First, the control mechanisms that 
block translation are over-come by the elevated GzmB mRNA levels. Second, the 
mediators that control GzmB translation are directly or indirectly affected by the loss 
of Tcf-1. Control of GzmB translation is not well understood and further experiments 
are needed to address these questions.Accordingly, it remains to be determined in 
further experiments if GzmB is a direct target gene of Tcf-1 regulation. To test 
whether Tcf-1 binds to the GzmB locus we are currently performing Tcf-1 chromatin 
immunoprecipitation followed by parallel sequencing (ChIP-seq) analysis of NK cells. 
The aim is to use the ChIP-seq data to identify Tcf-1 binding sites and to relate this 
information to the presence of activating (histone H3 trimethylated at lysine 4, 
H3K4me3) and repressive (H3K27me3) histone marks. Our hypothesis is that in wild 
type NK cells, Tcf-1 is bound to the GzmB locus and that this is associated with 
repressive histone marks. Consequently, in Tcf-1 deficient NK cells we would expect 
the active histone marks to be more abundant. If we identify a Tcf-1 binding 
sequence within the GzmB locus, we would need to perform reporter assays to 
confirm that Tcf-1 binding to this site results in repression or activation of GzmB 
transcription. 
If direct binding of Tcf-1 to the GzmB promoter region cannot be shown, the 
observed regulatory effects of Tcf-1 on GzmB expression must involve further, yet 
unidentified molecular components. The iNK to mNK transition is impaired in the 
absence of the two T-box transcription factors T-bet and Eomes (Gordon et al., 2012). 
This process appears similar to our observations on Tcf-1 deficiency. Eomes is a 
direct target of Tcf-1 in CD8 T cells (Zhou et al., 2010). Eomes and T-bet 
coordinately regulate the expression of key effector molecules in cytotoxic 
lymphocytes such as Perforin, Granzymes and INFγ (Cichocki et al., 2013; Pearce et 
al., 2003; Szabo et al., 2000). Therefore, T-bet and Eomes may be downstream 
targets of Tcf-1 in NK cell development. While Eomes levels in BM NK cells that lack 
Tcf-1 did not significantly change, T-bet levels were slightly but significantly 
increased (around 30%). T-bet expression levels were reduced to normal in the p33 
and the p45 Tg Tcf7-/- NK cells, respectively (data not shown). Thus, in addition to a 
possible direct effect, Tcf-1 might also control GzmB expression indirectly through 
the repression of T-bet. Our Chip-seq analysis may shed light on this question as 
well. 
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3.3 NK cell function in the absence of Tcf-1 
We tested whether Tcf7 deficient NK cells are able to mediate normal effector 
functions. Upon priming of mice with poly IC, wild type and Tcf7 deficient NK cells 
comparably induced CD69 and expressed GzmB and Perforin. In response to target 
cells, Tcf7 deficient NK cells normally released cytokines, chemokines and granule 
contents (Lamp-1). However, their ability to kill target cells in vitro and particularly in 
vivo was impaired. Rather than killing target cells, NK cells themselves underwent 
increased cell death upon the recognition of susceptible target cells. Using inhibitors, 
we found that the increased cell death upon target cell recognition was prevented by 
blocking the activity of GzmB or Cathepsin C. Moreover, the increased cell death 
upon target cell exposure was prevented when Tcf-1 defcient NK cells also lacked 
GzmB (Fig. 32).  
Based on the data in this report our working model is that under steady state 
conditions, Tcf-1 suppresses GzmB levels. In an inflammatory context, NK cells are 
primed and this leads to a down-regulation of Tcf-1 and NK cells gain their full 
cytotoxic potential through the expression of GzmB. Indeed, we found that Tcf-1 is 
strongly decreased yet still expressed at low levels in NK cells of Poly IC primed mice 
(Fig. 9).  Low levels of Tcf-1 may restrict GzmB production and thus prevent GzmB 
mediated self-inflected damage. If an inflammation is reaching an extent that is 
dangerous for the organism, Tcf-1 expression may shut off, leading to more free 
GzmB in the cytoplasm. This may induce apoptosis of highly activated NK cells that 
potentially harm the host itself (Fig. 35 and 36).  
 
It remains to be explored in future experiments if the enforced expression of the Tcf-1 
Tgs prevents maturation (N-terminus, p45) and maintains GzmB repression (p33) 
during viral infections such as the mouse cytomegalovirus (MCMV). Furthermore, it 
has to be determined if such Tg expression leads to decreased cytotoxicity and/or 
self inflected death. Since it has been suggested that immature NK cells have a very 
low cytotoxic potential (Huntington et al., 2007), it remains to be tested if the p45 Tg 
NK cells show a decreased functional competence to respond to tumor target cells 
(Fig. 34). This would allow to better describe the relationship between maturation 
markers and cytotoxic potential.  
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GzmB mediated self-inflected damage may be a naturally occurring mechanism to 
remove terminally differentiated effector cells. This mechanism may dampen immune 
responses and prevent damage to host tissue by highly activated NK cells. Tcf-1 
would represent a major regulator of this process. Controlling Tcf-1 expression is 
thus expected to be key in the maturation and survival of NK cells during an immune 
response. It will be important to elucidate the specific signals which regulate Tcf-1 in 
vivo during the immune response. A Tcf-1 GFP reporter mouse would therefore 
represent a useful tool. 
 
 
Figure 36. Schematic representation of the model that we developed based on the results 
shown and discussed in this thesis. 
The Wnt signal mediating N-terminal domain of Tcf-1 is crucial to prevent the maturation of iNK cells 
and a subset of mNK cells, whereas the suppressor (p33) activity of Tcf-1 is vital to ensure the 
survival of expanding mNK cells and for the suppression of GzmB. In steady state conditions Tcf-1 
suppresses GzmB, whereas in an inflammatory context, Tcf-1 levels may decrease. This leads to 
GzmB expression and up-regulation of the maturation markers KLRG1 and CD11b and the 
downregulation of CD27 (indicated in violet, purple and yellow, respectively) and subsequent target 
cell killing upon recognition. During this process some Tcf-1 is still present to prevent GzmB mediated 
self-inflected damage. In a persistent inflammatory context Tcf-1 levels further decline what leads to 
increased GzmB expression and self-inflected death. Curves indicate Wnt signaling (blue), Tcf-1 
expression (red), maturation (yellow) and GzmB expression (green). 
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NK cells that have been attracted to the sites of inflammation could represent a 
highly desirable vehicle for viruses to ascertain rapid spread throughout the host. 
Viruses that do not infect endothelial cells are unable to enter or leave the 
bloodstream to infect peripheral tissues. Previously, it has been shown that GzmA 
and GzmB double deficient mice have higher virus titers upon infection with the 
cytopathic pox-viruses. The authors suggest that this observation is linked to the 
enhanced survival of CTLs and NK cells due to their inability to commit GzmB-
mediated suicide. Therefore, the virus might use these cells as Trojan horses to 
extravagate and infiltrate other organs (Balkow et al., 2001). This suggests that 
GzmB mediated self-inflected death might also represent an important mechanism to 
prevent viral spread by activated and highly mobile cytotoxic cells. 
 
Based on the findings shown in my thesis we propose a model where Tcf-1 plays a 
major role for the suppression of the highly cytotoxic effector molecule GzmB in NK 
cells, thereby preventing self-inflected damage in these cells. Concordantly, the Wnt 
signal mediating N-terminal domain of Tcf-1 is crucial to prevent the maturation of 
iNK cells and of a subset of mNK cells. Our data suggest that upon inflammation, 
Tcf-1 levels may decrease, that in turn would lead to GzmB expression and to 
terminal maturation. During the course of an immune response, Tcf-1 levels might 
further decline, triggering GzmB mediated self-inflected damage of highly activated 
NK cells (Fig. 36). This mechanism might be important to remove terminally 
differentiated effector NK cells and thus to dampen immune responses in order to 
prevent collateral damage of the host tissue. Blocking Tcf-1 expression in highly 
activated NK cells may therefore be a way to induce self-inflected cell death. In the 
context of autoimmune inflammation this mechanism could be exploited to eliminate 
effector cells that attack host tissue. The identification of the factors that modulate 
Tcf-1 expression during inflammation may therefore allow the identification of 
potential therapeutic targets. 
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4 Methods 
Mice 
C57BL/6 (B6) mice were purchased in Harlan OLAC (The Netherlands). CD45.1 
congenic B6 were bred in the specific pathogen free animal facility of our institut. 
Tcf7-/- (Verbeek et al., 1995), Tcf7-p33 and Tcf7-p45 (Ioannidis et al., 2001), 
conductinlacZ (Lustig et al., 2002), β-cateninlox/lox (Huelsken et al., 2001), γ-cateninlox/lox 
(a kind gift from Prof. Jörg Huelsken),  Vav-Cre transgenic (Almarza et al., 2004; de 
Boer et al., 2003), GzmB−/− (GzmB−/−/ΔPGK-neo) (Pham et al., 1996; Revell et al., 
2005) (a kind gift form Prof. Christoph Borner) mice have been described. Β-catenin 
Flox/Flox γ-catenin Flox/Flox, Vav-Cre+ mice have been crossed by Camille Grandclément 
in our lab and the GzmB−/− (GzmB−/−/ΔPGK-neo) Tcf7-/- have been bred by myself. 
For BM chimeras, 2:1 or 3:1 mixtures of experimental (CD45.2+) and wild type 
(CD45.1+) BM cells were used (3-6x106 cells total). Chimeras were tail bled at the 
indicated time points and lymphoid tissues were analyzed 2-12 months after 
reconstitution.  
 
Flow cytometry 
Spleen and bone marrow cells were treated with ACK (NH4Cl 0.15M, KHCO3 1 mM, 
EDTA 0.1 mM, pH 7.3) to remove erythrocytes. Subsequently cells were incubated 
with Aquadead (Invitrogen) (to exclude dead cells) and anti-CD16/32 (2.4G2) 
hybridoma supernatant to block Fc receptors before staining with fluorescent mAbs 
to NK1.1 (PK136), CD49b (DX5), CD122 (TMB1), KLRG1 (2F1), CD27 (LG.7F9), 
CD11b (M1/70), CD69 (VEA), CD84 (mCD84.7), CRACC/SLAMF7 (235614), Ly-108 
(13G3-19D), Ly-9 (Ly9ab3, BioLegend), 2B4 (244F4), CD16 (93, BioLegend), (LFA-1 
(FD44.8), Ly-49A (JR9/YE1/48.10.6/A1), Ly-49H (3D10), Ly-49D (4E5), Ly-49G 
(4D11), Ly-49C/I (5E6), Ly49F (HBF), Ly49I (YLI90), NKp46 (29A1.4), CD3ε (17A2), 
CD19 (6D5), BP-1 (6C3), B220 (RA3-6B2), CD45.1 (A20), CD45.2 (104.2), CD43 
(S/7), CD8a (53-6.7), CD25 (GCG1), GR-1 (Ly6G), Sca1 (D7), Ter119 (Ter119), CD4 
(RM4-5), F4/80 (F4/80), CD90.2 (BOH12), TCRβ (H57), TCRγδ (GL3)  and CD117 
(ACK2) (if not indicated otherwise from BD Biosciences). A cocktail of FITC-
conjugated anti-TCRβ, TCRγδ, CD3ε, CD4, CD8, CD11b, B220, NK1.1, Ter119 and 
GR-1 mAbs was used to gate lineage-negative (lin-) cells.  Intracellular staining for 
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GzmB (16G6, invitrogen), Perforin (OMAK-D, e-Bioscience), GzmA (3G8.5, Santa 
Cruz) IFN-γ (XMG1.2, e-Bioscience), T-bet (eBio4B10, e-Bioscience), Eomes 
(Dan11mag, e-Bioscience), MIP-1 alpha (39624, e-Bioscience), Tcf-1 (C63D9, Cell 
Signal) and Lef (C12A5, Cell Signal) was performed using the BD Cytofix/Cytoperm 
Fixation/Permeabilzation Kit (BD Biosciences) for IFN-γ, MIP-1α, Bcl-2 (PharMingen) 
and Bcl-XL (7B2.5, SouthernBiotech) or the Transcription factor staining buffer set” 
(eBioscience) for GzmB, GzmA, T-bet, Eomes, Tcf-1 and Lef according to the 
manufacturer’s protocol. Data were acquired on an LSRII flow cytometer (BD 
Biosciences) or a FACSCanto flow cytometer (Becton Dickinson, San Jose, CA) and 
analyzed with FlowJo (Tree Star, Ashland, OR). Alternatively cells were subjected to 
sorting on a FACSAria machine (Becton Dickinson, San Jose, CA). 
 
LacZ staining 
For measuring LacZ activity, cells were counted and resuspended at 20x106 cells per 
mL in HBSS (Gibco) containing 2% FCS, 10mM Hepes (Gibco) and 1% Pen-Strep 
(Gibco)). 2x106 cells were incubated for 10 minutes at 37°C and loaded with pre-
warmed Fluorescein Di-β-D-Galactopyranoside 2mM (FDG, Invitrogen) in H2O for 1 
minute. Cells were then quenched with complete HBSS and left for 90min on ice 
before washing. The cells were surface stained for flow cytometry as described 
previously. The vital dye 7-AAD (Biolegend) was added 10 min prior to the FACS 
analysis. Samples were run on LSRII or FACScanto flow cytometers (Becton 
Dickinson, San Jose, CA) and analyzed using FlowJo software (Tree Star, Ashland, 
OR).  
 
NK cell expansion 
Splenic NK cells were purified by non-adherence to nylon wool followed by 
depeleting non-NK cells using the NK Cell Isolation Kit II and a MACS separator 
(Miltenyi Biotec). Purified NK cells were cultured for 5 days in DMEM with 10% FCS, 
Gentamicin (10mg/ml), 2-Mercaptoethanol (50mM), MEM NEAA (0.1mM), L-
Glutamine (4 mM) and 500mg/ml recombinant human IL-2 (a gift from N. Rufer, 
University of Lausanne). After 5 d, cells were harvested and stained for surface 
antibodies and for Annexin V (PE Annexin V Apoptosis Detection Kit I, BD 
Pharmigen) according to the manufacturer’s protocol. To identify DNA strand breaks 
we performed a TUNEL staining (In Situ Cell Death Detection Kit, Roche) that labels 
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free 3’-OH termini with modified nucleotides in an enzymatic reaction. Data were 
acquired on an LSRII flow cytometer (BD Biosciences). 
 
In vitro NK cell activation to measure cytokine and chemokine release 
Spleen cells (2 × 106) from polyinosinic-polycytidylic acid (Poly IC) primed mice were 
stimulated with plastic immobilized mAbs to NK1.1 (PK136, BioXCell) (5mg/ml), 
NKG2D (191004, R&D Systems) (5 mg g/ml), NKp46 (29A1.4 eBiosciences) (2.5 
mg/ml), Ly49D (4E5, BD Pharmingen) (2.5 mg/ml) or by target cells RMA (H-2b), 
RMA/S (MHC-Ilow), RMA-H60, RMA-m157 or YAC-1 cells (2 × 106) or by the addition 
of PMA (50 ng/ml) and Ionomycin (1 mg/ml). GolgiPlug, GolgiStop and LAMP mAb 
(1D4B, eBiosciences) were added after 1 h of culture and the cells were harvested 4 
h later. Cells were incubated with Aquadead (Invitrogen) (to exclude dead cells) and 
anti-CD16/32 (2.4G2) hybridoma supernatant before staining with fluorescent mAbs 
to NK1.1 (PK136), NKp46 (29A1.4), CD3ε (17A2), CD19 (6D5) (all from BD 
Biosciences). Intracellular staining for IFNγ (XMG1.2, e-Bioscience) and MIP-1 alpha 
(39624, e-Bioscience) was performed using the BD Cytofix/Cytoperm 
Fixation/Permeabilzation Kit (BD Biosciences). Cells were analyzed on a FACSCanto 
flow cytometer (BD Biosciences) and analyzed with FlowJo (Tree Star).  
 
FLOKA ASSAY 
Mice were intravenously injected with 100ug polyinosinic-polycytidylic acid (Poly IC) 
(Labforce, tlrl-pic) to prime the NK cells. 24 hours later the mice were sacrificed and 
the spleens were harvested. The NK cell numbers (effectors) were determined by 
FACS analysis. Target cells RMA (H-2b), RMAS MHC-Ilow, RMA-H60 or RMA-m157 
were resuspended at a concentration of 1x107 cells/ml in PBS containing 0.3 µM 
CFSE (5- and 6-carboxyfluorescein diacetate succinimidyl ester, Molecular Probes) 
and incubated for 5 min at 37°C in the dark. CFSE labelled cells were washed three 
times in DMEM containing 10% FCS. Subsequently the effector cells were added 
and the cells were cultured at 37° in a FACS tube with 500 ul of medium (DMEM and 
10% FCS) at an effector: target ratio of 1:1, 3:1 or 10:1 (10 000 target cells were 
used and the effectors were adjusted accordingly). As a control targets and effectors 
were cultured separately. Four hours later 10 ul of 7AAD (PD Pharmigen) was added. 
The percentage of death cells (7AAD+) cells within the CFSE positive target cell 
population was determined by FACS analysis like described earlier. The 
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spontaneous cell death within the target cells that were cultured without effectors was 
used to calculate the percentage of cells that underwent cell death due to killing. 
Inhibitors used: Caspase inhibitor Z-VAD-FMK (Promega), GzmB inhibitor Z-AAD-
CMK (Enzo), Cathepsin C inhibitor, Gly-Phe-DMK (MP BIOMEDICALS) 
 
In vivo target cell rejection 
Mice were injected intra peritoneal with 100 µg Poly IC (Sigma-Aldrich). 24 h later a 
1:1 mixture of 1 ×  107 H-2b (labeled 2.0 µM CFSE [Invitrogen]) and 1 ×  107 β2m-
knockout (MHC-Ilow) splenocytes (labeled with 0.2 µM CFSE) were injected 
intraveniously. Spleens of recipient mice were analyzed 24 h later for the presence of 
transferred cells. The percentage of specific rejection was calculated as follows: 100 
− [(percentage of H-2b cells (CFSEhi) final/percentage of β 2m-knockout cells 
(CFSElow) final)/(percentage of H-2b cells (CFSEhi) initial/percentage of β2m-knockout 
cells (CFSElow) initial)] × 100.  
 
Confocal microscopy  
BM mNK cells or splenic NK cells at day 5 of IL-2 stimulation were FACS sorted to 
get rid of non-NK cells. 5x104 NK cell blasts or 1x105 mNK cells/ 100uL were put on 
Poly-L-Lysin (0.1%) coated Super-Frost slides (VWR International). Subsequently 
cell were fixed for 10 min in 3.7% PFA at room temperature (RT). After three washing 
steps with PBS cells were permeabilized for 10 min at RT with 0.2% Triton in PBS. 
After washing cells were blocked for 1 hour with PBS+15% Goat serum (SIGMA) and 
then 1 hour in 15% Rat serum (SIGMA). Following an over night incubation at 4C° 
with the primary antibody (GzmB (BAF1865) (R&D); Goat anti-Mouse; biotynilated; 
and Anti mLAMP1 (1D4B) (BioLegend) Rat anti-Mouse) cells were washed rigorously 
with BPS and stained for 1 hour at RT with the secondary antibodies in blocking 
solution (Alexa-Fluor-488 -Strepatvidin) (invitrogen) and Alexa-Fluor- 555 Goat anti-
Rat  (Life technologies)). After being washed cells were mounted in ProLongGold 
antifade reagent with DAPI (invitrogen) and covered with a glass. Samples were 
examined with a LSM 510 confocal microscope (Zeiss) and images were recorded in 
multitracking mode.	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B-ALL induction 
For B-ALL like disease induction BM cells from β2m deficient mice were infected with 
the MCMV-bcr-ablp185/IRES-gfp virus. Before the viral supernatant was collected 
after transient transfection of 293T cells. The β2m deficient BM cells were cultured 
with the viral supernatant for 1 hour in the presence of 10ng/mL IL7, 10% WEHI 
supernatant (as a souce of IL3) and 5µg/mL of Polybrene. The infected BM cells 
were subsequently cultured for 7 days at 37°C, 5% CO2 in RPMI medium containing 
5% FCS. After 7 days of culture, more than 90% of bone-marrow cells were B220+, 
CD43+, BP1+ and GFP+. For tail vein injections, 2 x 106 infected bone marrow cells 
were re-suspended in 200µL of PBS and injected via the tail vein in B6 or Tcf7-/- 
recipient mice.  In some cases, NK cells were depleted with the NK-depleting 
antibody PK136 (BioXcell, 200µg/mouse, IV) 2 days before the injection of B-ALL 
cells and the depletion was then performed once in a week. Mice were checked daily 
for the onset of the disease. Blood samples were analyzed 10 days after the injection 
of B-ALL cells to follow the disease. Sick mice were killed and analyzed for spleen 
weights, NK cell counts and the presence of leukemic cells. 
 
Western Blot 
Western blots on total cell lysates from FACS sorted mNK, splenic NK or IL-2 
stimulated NK cells (100 000-500 000 cells per lane) were performed as described 
(Ioannidis et al., 2001). Blots were incubated overnight at 4°C with primaryantibodies: 
Rb polyclonal Ab anti-GzmB (abcam), PI-9 (PI9-17) (Santa Cruz Biotechnology) or 
anti-Tubulin (B-5-1-2, Sigma). Western blots were revealed with HRP- conjugated 
anti-mouse and anti-rabbit Abs (Sigma) followed by enhanced chemiluminescence 
detection (Pierce, Rockford, IL).  
 
Microarray 
Global gene expression profiles of FACS-purified BM mNK cells (CD3-CD19-
CD122+NK1.1+DX5+) isolated from Tcf7+/+ and Tcf7-/- mice were established using 
Affymetrix arrays. A minimum of 3x6 Tcf7+/+ and Tcf7-/- mice were sorted. RNA was 
extracted using Tryzol Reagent (Invitrogen). Gene expression profiling was 
performed according to the manufacturer’’s protocol (Affymetrix). Labeled cRNA 
(from total RNA) was generated and applied to Affymetrix muU74Av2 microarray. All 
experiments were performed twice using RNA samples from two independently 
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sorted cell subsets. Results were analyzed using Microarray Analysis Software v4 
and v5 (Affymetrix). 
 
Quantitative PCR 
Total mRNA was isolated from sorted cells using RNA easy kit (Qiagen), SV Total 
RNA Isolation System (Promega) or High Pure RNA Tissue Kit (Roche). First strand 
DNA was synthesized with oligo-dT (Amersham Biosciences) and AMV reverse 
transcriptase (Roche Diagnostics). RNA was digested with RNAse One (Promega) 
and DNA purified with Mini Elute PCR purification Kit (Qiagen). Quantitative PCR 
reactions were performed with the LightCycler FastStart DNA Master SYBR Green I 
kit and run on the LightCycler II (Roche Diagnostics). Amplification plots were 
analyzed using the second-derivative method with LC data analysis 3.5 software 
(Roche), and the relative quantification was determined using the LightCycler relative 
quantification software 1.0 (Roche). 
 
Statistical Analysis 
Statistical significance was determined using an unpaired two-tailed Student t test for 
unequal variances. P values are indicated as *P < 0.05, **P < 0.01, ***P < 0.001, and 
ns, statistically not significant. The statistical significance of differences between 
groups of data was calculated using a one-way analysis of variance (one-way 
ANOVA) along with the Dunnet's post-test to adjust for multiple comparisons, using a 
95% confidence interval. 
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